An investigation of the zinc binding characteristics of the RING finger domain from the human RBBP6 protein using heteronuclear NMR spectroscopy. by Mulaudzi, Takalani
 An investigation of the zinc binding characteristics of the RING finger 
domain from the human RBBP6 protein using heteronuclear NMR 
spectroscopy 
 
 
 
 
 
 
 
Takalani Mulaudzi 
 
 
A mini-thesis submitted in fulfilment of the degree of M.Sc. (Structural Biology) in the 
Faculty of Science, University of the Western Cape 
 
 
Supervisor: Dr D.J.R. Pugh 
 
November 2007 
 
 
 
 
 
 ii
Keywords 
 
15N-HSQC 
1H-113Cd-HSQC 
Cadmium ion 
Coordination 
Expression 
NMR  
RBBP6  
RING  
Spectroscopy 
Zinc ion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii
Abstract 
 
An investigation of the zinc binding characteristics of the RING finger domain from 
the human RBBP6 protein using heteronuclear NMR spectroscopy 
Takalani Mulaudzi 
M.Sc. (Structural Biology) thesis, Department of Biotechnology, Faculty of Science, 
University of the Western Cape. 
 
Retinoblastoma binding protein 6 (RBBP6) is a 250 kDa human splicing-associated 
protein that is also known to interact with tumour suppressor proteins p53 and pRb and to 
mediate ubiquitination of p53 via its interaction with Hdm2. RBBP6 is highly up 
regulated in oesophageal cancer, and has been shown to be a promising target for 
immunotherapy against the disease. RBBP6 is also known to play a role in mRNA 
splicing, cell cycle control and apoptosis. 
 
RBBP6 contains a RING finger domain, a hallmark of E3 ubiquitin ligases, which is 
essential for its interaction with Hdm2.  RING fingers are well-known structural motifs 
coordinating two zinc ions in a cross-braced manner by means of eight conserved 
cysteine or histidine residues. Sequence alignments suggest that the RBBP6 RING finger 
can be classified as a member of the U box family, which do not require zinc ions in 
order to fold, although they adopt the same structure as RING fingers, raising the 
question as to whether zinc is required in order for the RBBP6 RING to fold.  
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Previous analysis of a fragment of RBBP6 containing the RING finger domain showed 
that it contained an unstructured region at the N-terminus, which hampered efforts to 
investigate the protein using NMR. Here we report the truncation, expression and NMR 
analysis of two shortened RING constructs from which the unstructured region has been 
removed. Fragments shortened by 13 and 19 amino acids respectively were expressed as 
soluble GST–fusions and samples prepared for NMR analysis. 
 
1D and 2D NMR showed that the longer of the two shortened constructs adopted the 
same fold as the original RING construct, whereas the shorter was unfolded, from which 
we deduce that the boundary of the RING domain lies between the two shortened 
constructs. 
 
Using NMR we showed that zinc is required in order for the protein to fold, and that zinc 
ions can be replaced by cadmium ions without significantly disrupting the structure. 
Using 1D directly detected 113Cd spectroscopy we were able to observe the cadmium ions 
bound into the protein, which to our knowledge, has never been done before for proteins. 
We were also able to observe coherence transfer between the cadmium ions and Hβ 
protons in the side chains of the coordinating cysteine residues, which will be used in 
future work to identify the residues involved in coordinating the zinc ions. 
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Chapter 1: General Introduction 
1.1 Introduction  
Retinoblastoma binding protein 6 (RBBP6) is a 250 kD human protein that is known to 
interact with tumour suppressor proteins p53 and retinoblastoma (pRb) (Sakai et al., 
1995; Simons et al., 1997) and to be essential for the ubiquitination of p53 by Hdm2 (Li 
et al., 2007). RBBP6 is highly expressed in oesophageal cancer cells and has been shown 
to be a promising target for immunotherapy against the disease (Yoshitake et al., 2004). 
In addition to its interaction with p53 and pRb, RBBP6 is also known to be involved in a 
variety of functions including regulation of cell cycle control, apoptosis and pre-mRNA 
splicing (Simons et al., 1997; Witte and Scott, 1997; Vo et al., 2001). 
 
RBBP6 contains a RING finger domain, which is a hallmark of E3 ubiquitin ligases, and 
which is essential for the interaction with Hdm2 (Li et al., 2007). RING fingers typically 
bind two Zn2+ ions, coordinated by eight conserved cysteine or histidine residues, 
typically forming a C3HC4 motif, although a number of other possibilities including 
C4C4 and C4HC3 have been reported. Sequence alignments suggest that the RBBP6 
RING is either a C4C4 or possibly a novel C3NC4 RING. Sequence alignments show 
furthermore that RBBP6 could also be classified as a member of the U box family, which 
do not bind Zn2+, and in which the Zn2+ coordinating bonds are replaced by hydrophobic 
interactions. However they adopt the same structures as RING fingers. The aim of this 
work was to use NMR to investigate the Zn2+ binding characteristics of the RBBP6 RING 
finger domain in order to establish whether Zn2+ was required for folding, and whether 
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Zn2+ could be replaced by Cd2+, as had been done successfully in a few other proteins, if 
possible, to establish the identities of the residues involved in coordinating the Zn2+ ions. 
 
1.2 Retinoblastoma binding protein 6 (RBBP6) 
RBBP6, also known as PACT (p53-Associated Cellular protein-Testes derived), P2P-R 
(Proliferation Potential protein-Related) or RBQ-1 (RB-binding Q-protein) is a 250 kD 
protein that interacts with tumour suppressor proteins p53 and pRb (Sakai et al., 1995; 
Simons et al., 1997; Gao et al., 2002). A shorter three-domain form of the protein, 
consisting of the DWNN domain, a Zinc finger and a RING finger domain, is found in all 
eukaryotic organisms (see Fig 1.1). In vertebrates and in insects the protein has a long C-
terminal extension which includes the Rb-binding domain, p53-binding domain, an SR 
region known to play a role in mRNA splicing, and a nuclear localisation domain (Pugh 
et al., 2006).  
 
Similar to other SR domain-containing proteins, RBBP6 localises to nuclear speckles and 
associates with Sm antigens in nuclear extracts, suggesting a role for RBBP6 in mRNA 
splicing (Simons et al., 1997). Mpe1p, which is the yeast homologue of RBBP6, is an 
essential protein, which forms part of the yeast cleavage and polyadenylation complex. 
Neutralisation of Mpe1p by the addition of anti-Mpe1p antibodies completely inhibited 
polyadenylation of mRNA transcripts (Vo et al., 2001).  
 
The interaction of RBBP6 and p53 can strongly interfere with the binding of p53 to DNA 
(Simons et al., 1997). RBBP6 has been shown to reduce the transcriptional activity of 
 
 
 
 
 3
p53. Removal of RBBP6 using RNAi in cells resulted in the accumulation of p53, leading 
to inhibition of growth followed eventually by cell death, suggesting that RBBP6 is anti-
apoptotic (Li et al., 2007). Conversely Gao and Scott showed that over-expression of 
RBBP6 in cells promotes cell cycle arrest and mitotic apoptosis (Gao and Scott, 2002). 
Although these results would appear to be contradictory, together they suggest that 
RBBP6 plays an important poorly understood role in the regulation of p53 and hence, in 
the control of cancer. In support of this hypothesis RBBP6 has been shown to be highly 
expressed in oesophageal cancer and to be a promising target for immunotherapy against 
this form of cancer (Yoshitake et al., 2004). 
 
RBBP6 also interacts with pRb, which is known to facilitate terminal differentiation in 
cells. The interaction between RBBP6 and pRb is strongly inhibited by adenovirus E1a 
protein (Witte and Scott, 1997), which binds in the “pocket”, region of pRb, suggesting 
that RBBP6 may also bind in the “pocket” increasing the likelihood of the interaction 
playing a biological role.  
 
The presence of a RING finger domain and a ubiquitin-like domain has led to RBBP6 
being identified as an E3 ubiquitin ligase (Pugh et al., 2006). Li et al., recently reported 
that RBBP6 is required for ubiquitination of p53 via Hdm2 the human analogue of Mdm2 
protein (Li et al., 2007). This suggests a possibility for the RBBP6 RING finger domain 
to act as an E3 ubiquitin enzyme.  
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1.3 RING finger domains 
A RING finger is a cysteine rich domain containing a CX2CX9-39CX1-3HX2-3(C/H)X2CX4-
48CX2C consensus sequence (Joazeiro and Weissman, 2000; Capili et al., 2004), where X 
can be any amino acid (see Fig 1.2). Eight cysteine or histidine residues coordinate two 
Zn2+ ions in a cross-brace manner, in which the first and third Cys/His pairs coordinate 
the first Zn2+ ion and the second and fourth pairs coordinate the second Zn2+ ion (see Fig 
1.3). The spacing observed between the second and third Zn2+ coordinating pair is a 
unique character that is conserved amongst all RING finger domains, corresponding to 
the physical distance between the two coordination sites (Hanzawa et al., 2001; Pickart, 
2001; Capili et al., 2004). 
 
The overall secondary structure of the RING finger domain consists of a single three-
stranded anti-parallel β-sheet and an α-helix, connected by long loops, as shown in Fig 
1.4 (Kellenberger et al., 2005). The ability of the ~70 amino acid residue RING finger 
domain to fold independently is due to its ability to coordinate two Zn2+ ions, which 
stabilize the structure (Pickart, 2001). 
 
1.3.1 C3HC4, C3HHC3, C4C4 and C2H2C4 RING finger domains 
The initial consensus sequence for coordinating Zn2+ ions by RING finger motifs was 
defined as C3HC4 (Krishna et al., 2003), in which the first Zn2+   ion is coordinated by 
three cysteine residues and a histidine residue while the second Zn2+   ion is coordinated 
by four cysteine residues. Examples of the C3HC4 motif include the RAG1, MAT1, c-
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Cbl, IEEVH and BRCA1 proteins. The definition of the consensus sequence has recently 
expanded to include sequences such as C3HHC3, the C4C4, and the C2H2C4 motif.  
 
An example of the C3HHC3, which is also known as RING-H2, is provided by the EL5 
RING-H2 (Katoh et al., 2003). In this motif Cys 4 is replaced by a His residue. EL5 is 
related to proteins of the Arabidopsis ALT family and includes a transmembrane domain, 
a basic domain, a conserved domain and the RING-H2, which are named domain I-IV 
respectively. The long C-terminal domain is poorly conserved (see Fig 1.8a). The 
structure of the RING-H2 presents a ββα fold with large N- and C-terminal loops, which 
is similar to other RING finger motifs (Katoh et al., 2003).  
 
Examples of the C4C4 motif include the CNOT4 and p44 RING finger domains (Houben 
et al., 2005), both of which play a role in transcriptional regulation. Hdm2 is an E3 
ubiquitin ligase that plays a crucial role by regulating the amount of p53 via 
ubiquitination. It encodes a C2H2C4 motif at its C-terminal region, which coordinates 
two Zn2+ ions, and has recently been shown to adopt the same ββαβ fold as other RING 
fingers (Kostic et al., 2006).  
 
Fig 1.2 shows an alignment of RBBP6 RING finger against a number of RING motifs. 
The histidine (H) at position 4 has been replaced by an asparagine (N), and an extra 
cysteine (C) has been inserted immediately adjacent to the cysteine at position 3. Hence 
is not yet clear whether the RBPP6 RING finger should be described as a C4C4 or as a 
C3NC4 RING finger motif. 
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1.3.2 PHD (Plant homeodomain) RING-like domain 
Plant homeodomain (PHD) finger domains are structurally related to RING finger 
domains and can be characterized as a C4HC3 motif (Dul and Walworth, 2007). The 
conserved ~60 residue PHD finger domain occurs in over 400 eukaryotic proteins, many 
of which are involved in the regulation of gene transcription. The 3D NMR structure of 
the PHD of the Autoimmune regulator protein (AIRE1) is shown in Fig 1.5. The PHD 
adopts a ββαβ topology similar to classical RING finger or U box domains (Bottomley et 
al., 2005), although the α-helix forms part of the second Zn2+   ion coordination site 
rather than the first (see Fig 1.3) . In addition to Zn2+ coordination, stabilisation of the 
PHD finger domain also involves a network of hydrophobic residues, which surround a 
highly conserved tryptophan (Trp335), which is a feature common to all PHD domains 
(Bottomley et al., 2005). 
 
1.3.2 U box domain 
Zn2+ coordination by RING fingers is important for folding and stability, but it is not 
required in domains such as the U box, which lacks the metal coordinating residues. The 
U box motif was first identified in the yeast protein UFD2 (ubiquitin fusion degradation 
protein 2) and subsequently shown to be present in other eukaryotic proteins (Pringa et 
al., 2001). Although the U box lacks the Zn2+ coordinating residues, it adopts the same 
topology and 3D structure as RING fingers (Houben et al., 2005).  
 
In the U box domain the Zn2+ coordinating residues are replaced by a set of hydrophobic 
residues (see Fig 1.2) interconnected by salt bridges and hydrogen bonds, which stabilize 
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the U box domain (Andersen et al., 2004). Many of these residues are also conserved in 
the RING finger domains, however the degree of conservation is higher in the U box 
domains. For example, the RBBP6 RING finger domain can also be classified as a U box 
domain due to the conservation of the hydrophobic residues also found in the U box 
domain (Aravind and Koonin, 2000). However the presence of conserved cysteines, in 
addition to the hydrophobic residues, suggests that the RBBP6 domain does bind Zn2+ 
ions and is therefore a RING finger rather than a U box domain. U box domains, like 
RING fingers, act as E3 ubiquitin ligases and mediate ubiquitination in the same way as 
the RING finger domains (Aravind and Koonin, 2000).  
 
1.4 Functions of RING finger domains 
RING finger domains form a large group of Zn2+ coordinating proteins with wide range 
of functions (Pickart, 2001), which include ubiquitination, cell growth, differentiation and 
multimerization.  
 
1.4.1 Ubiquitination 
RING finger-containing proteins act as E3 ubiquitin ligases during ubiquitination. 
Ubiquitination refers to post-translation modification of proteins by covalent attachment 
of one or more ubiquitin monomers. Ubiquitination acts as a signal, activating a number 
of important pathways, including degradation of the ubiquitinated protein by the 26S 
proteasome, quality control, vesicular trafficking, receptor endocytosis, transcriptional re-
gulation and DNA repair. Since proteins are continuously synthesized in the cell they 
must also be degraded. Degradation is essential to the cell in order to supply amino acids 
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for new protein synthesis and to remove excess enzymes and transcriptional factors that 
are no longer needed or proteins that have been damaged.  
 
Ubiquitination is mediated by several enzymes, namely: (1) an E1 ubiquitin-activating 
enzyme, an E2 ubiquitin-conjugating enzyme/Ubc and (3) an E3 ubiquitin ligase. During 
ubiquitination the E1 enzyme activates ubiquitin in an ATP-dependant manner, forming a 
thiol-ester bond between the E1’s catalytic cysteine and ubiquitin’s C-terminus. The E1 
enzyme then transfers ubiquitin to the catalytic cysteine of the E2 enzyme (Zolk et al., 
2006). E3 ubiquitin ligases play a role in substrate recognition, during the transfer of 
ubiquitin to the E3 ubiquitin ligase (Fig 1.6), and bind both the E2 and the target. E3 
ubiquitin ligase transfers the activated ubiquitin from the E2 enzyme to the ε-amino 
group of a lysine on the target protein, thereby forming an iso-peptide bond. E3 ubiquitin 
ligases therefore play a crucial role in recognizing and selecting the protein that is to be 
degraded (Pringa et al., 2001; Zolk et al., 2006). Like other RING fingers containing 
proteins, RBBP6 mediates ubiquitination of p53 via its interaction with Hdm2 (Li et al., 
2007). 
 
E3 ubiquitin enzymes are classified into two main groups: those containing a HECT 
(Homologous to the E6-AP Carboxyl Terminus) domain and the larger group of those 
containing a RING finger domain, or the closely related U box domain (Pickart, 2001). 
The HECT domain is made up of ~350 residues (Pickart, 2001). It catalyzes the 
ubiquitination reaction by forming a Ub-thioester intermediate between ubiquitin and a 
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conserved cysteine residue in the HECT domain (Kumar et al., 1997; Huang et al., 1999; 
Joazeiro and Weissman, 2000).  
 
A family of HECT domain proteins called the WW domains recognizes a specific 
sequence PPxY (PY motif) and other proline-rich motifs. The WW domains include 
proteins with a variety of functions including Nedd4 and E6-AP. Nedd4 mediates the 
ubiquitination and downregulation of an epithelial cell sodium channel (maintains 
electrolyte homeostasis), whereas the E6-AP mediates ubiquitination and degradation of 
p53 protein induced by papillomavirus (Huang et al., 2000).  
 
1.4.2 Other functions of RING fingers  
RING finger-containing proteins play vital roles in cell growth, differentiation and 
multimerization (Katoh et al., 2003). Li et al., showed that knocking down RBBP6 in 
mice leads to early embryonic lethality, suggesting that RBBP6 is important for cell 
growth and embryonic development (Li et al., 2007). Recombinant-activating gene 1 
(RAG1) plays a role in the recombination of immunoglobulin and the T cell receptor 
genes. RAG1 encodes a highly conserved C3HC4 RING finger at its N-terminal region, 
as well as C2H2 Zn2+ finger motifs at its N and C-terminal ends respectively. One of the 
C2H2 Zn2+ finger motifs forms a dimer with C3HC4 RING finger, suggesting that the 
RING domain is involved in protein-protein interactions (Rodgers et al., 1996; 
Yurchenko et al., 2003).  
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1.5 Chemistry of Zn2+ coordination 
Zn2+ coordination is important for folding, structural stability and functional activity of 
metalloproteins (Houben et al., 2005). Transcription factors and other enzymes require 
Zn2+ for their function. Zn2+ binding proteins are classified as those in which Zn2+ ions 
serve either a catalytic or structural purpose. The focus of this review is on Zn2+ binding 
proteins, which Zn2+ serves a structural purpose. Examples of Zn2+ binding proteins 
include C2H2, C3H and C4 Zn2+ fingers and RING fingers. Zn2+, unlike other divalent 
ions, is ligated by ligands such as Cys and His residues, although it can also be found 
coordinated by side chains of Asp or Glu (Dudev and Lim, 2003). Zn2+ adopts a 
tetrahedrally, pentahedral or octahedral coordination, depending on the protein and the 
solvent accessibility of the metal binding site. The presence of more than one His, Asp or 
Glu side chains increases the chances of a tetrahedral coordination over 
octahedral/pentahedral coordination, regardless of the nature of the metal binding site. 
However tetrahedral coordination is the most stable and is known to occur in all 
structural Zn2+ binding sites in proteins (see Fig 1.7). Zn2+ favours tetrahedral 
coordination because it is buried away from the solvent, and because polarizable Cys side 
chains transfer more charge than water, neutralising the positive charges on Zn2+  (Dudev 
and Lim, 2003).  
 
Zn2+ binding sites in proteins are also accessible to heavy metals like Cd, Hg and Pb. The 
C4 protein motifs bind Cd ion and Pb ion more tightly than Zn2+ ion, whereas the C2H2 
and C2HC protein motif bind Zn ion more tightly. The larger radius of Cd2+  (0.95 Å) 
compared to (0.75 Å) for Zn2+ results in Cd-N bonds (His) and Cd-S (Cys) of 2.1-2.3 Å 
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and 2.6 Å respectively, compared to 2.1 Å and 2.3 Å for Zn-N (His) and Zn-S (Cys) 
(Dudev and Lim, 2003). 
 
1.6 The use of heteronuclear NMR to investigate Zn2+ binding in RING fingers. 
Heteronuclear NMR spectroscopy has been used successfully to demonstrate the 
requirement of Zn2+ ions for folding of RING finger domains as well as to directly 
identify the residues responsible for coordinating the two Zn2+ ions (Hanzawa et al., 
2001; Katoh et al., 2003; Capili et al., 2004). The 15N-HSQC spectrum of a protein is a 2-
dimensional spectrum in which each resonance corresponds to one backbone NH group, 
with the horizontal coordinate corresponding to the chemical shift of the proton and the 
vertical coordinate corresponding to the chemical shift of the attached nitrogen (see Fig 
1.8b). Exceptions are the pairs of peaks corresponding to side chain NH2 groups of 
asparagine and glutamine residues, which can be found at the right hand corner of the 
spectrum. Proline residues do not appear in the 15N-HSQC spectrum, because they lack 
backbone NH groups. In order to be observable the N nuclei need to be 15N isotopes 
rather than the more common 14N, which is accomplished by expressing the protein 
sample in bacteria grown on media in which the only source of nitrogen is 15N-enriched 
ammonium chloride (Rehm et al., 2002).    
 
The dispersion of the resonances in the 15N-HSQC of a folded protein is significantly 
greater than for an unfolded protein, making the 15N-HSQC spectrum an effective probe 
of protein folding, and consequently an effective indicator of the requirement of proteins 
to bind Zn2+. Using this method it was demonstrated that the addition of EDTA caused 
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unfolding of the RING finger from EL5 (see Fig 1.8c).  Addition of EDTA resulted in the 
loss of a number of resonances whereas addition of Zn2+ restored the spectrum to its 
original state (Fig 1.8d). This suggests that coordination of Zn2+ ions by EL5 RING-H2 is 
essential for folding and structural stability (Katoh et al., 2003). 
 
Human homolgous of Drosophila Ariadne (HHARI) is a protein containing two RING 
finger domains (RING1 and RING2) separated by a cysteine rich domain called an “In 
Between RING” domain (see Fig 1.9a). RING2 adopts a 3D fold, which is different from 
classical RING fingers because His4 and Cys8 in classical RING finger motif are not 
conserved. As confirmed by mutational studies and Zn titration experiments, ICP-OES 
(Inductively coupled plasma optical emission spectroscopy) measurements demonstrated 
that there is 1:1.3 ratio of RING2 to Zn2+ content, which suggests that RING2 coordinate 
only one Zn2+ ion. The requirement for Zn2+ for folding of RING2 was also investigated 
using 15N-HSQC NMR spectra. The spectrum in Fig 1.9 shows that RING2 is folded 
when expressed in the presence of Zn2+, but unfolded when expressed in the absence of 
Zn2+ (Capili et al., 2004). 
 
1.7 The use of 113Cd exchange experiments to study Zn2+ coordination by RING 
finger domains  
NMR can be used to investigate Zn2+ coordination by replacement by Cd2+ ions. The 
identities of the residues involved in coordinating the two Zn2+ ions is typically inferred 
from (1) the pattern of conservation of Cys and His residues, which are known to be 
capable of forming coordination bonds with Zn2+ ions, and (2) the proximity of the 
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conserved residues to the Zn2+ ions in solved structure. NMR provides a method of 
directly identifying the amino acids coordinating the metal ion, by transfer of magnetic 
energy from the metal ion to protons within the coordinating amino acid. 
 
 In the case of cysteine the closest protons to the metal ion are the Hβ protons, which are 
separated from the metal ion by three covalent bonds plus the coordination bond (see Fig 
1.10). Magnetisation transfer between the metal ion and the Hβ proton can be observed 
using an HSQC spectrum similar to the one described in Section 1.6. However since Zn2+ 
nuclei have no NMR signal, another metal ion such as 113Cd2+, which does have an NMR 
signal and has similar chemical properties to Zn2+, must be used. It has previously been 
shown that Cd2+ can replace Zn2+ in proteins without significant disruption of the folded 
structure. Cd2+ is the most compatible ion to replace Zn2+ because its radius is only 
marginally larger than that of Zn2+  (0.99 Å as compared to 0.74 Å) (Hanzawa et al., 
2001). Although not large enough to disrupt the folded structure the increase in size is 
sufficient to perturb the 15N-HSQC spectrum of the protein. Exchange of Zn2+ by Cd2+ 
typically leads to the disappearance of resonances close to the coordination site 
accompanied by the appearance of resonances corresponding to the Cd2+  -bound form of 
the protein (Hanzawa et al., 2001; Houben et al., 2005).  
 
1.7.1 Replacement of Zn2+ by Cd2+ in the p44 RING domain 
The DNA (TFIIH) transcriptional factor IIH p44 plays a central role in the transcription 
activities of TFIIH. Mass spectrometry showed that the C-terminal C4C4 RING domain 
of p44 coordinates two Zn2+ ions (Houben et al., 2005; Kellenberger et al., 2005). The 
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structure of the domain resembles that of classical RING fingers, although the last β-
strand (β3), which is located at the C-terminus of C3HC4 RING fingers, is located at the 
N-terminus of the p44 domain.  
 
Zn2+ binding in p44 was investigated using NMR, following addition of 113Cd-EDTA to a 
Zn2+  -containing p44 protein sample to a final concentration of 4 mM. Exchange of Zn2+ 
by Cd2+ was completed within 6 hours, as monitored by the disappearance of some peaks 
and the appearance of new peaks on the 15N-HSQC spectrum, which show exchange 
between the Zn2+ -bound and Cd2+ -bound forms. Only a small number of resonances 
were affected, indicating that the exchange did not affect the integrity of the structure as a 
whole (see Fig 1.11A). The chemical shift differences (Fig 1.11A) were observed for four 
different regions: Cys345-Cys348, Cys360-Cys363, Cys368-Cys371 and Cys382-
Cys385. The exchange caused large chemical shifts perturbations for residues Gly347, 
Val362, Cys363, Cys371, Gly384, Cys385 and His387, which are most probably due to 
the breaking of hydrogen bonds between the amide protons of these residues and the 
sulfur atoms of the preceding cysteine residues.  
 
The 113Cd-HSQC spectrum in Fig 1.11B shows the coherence transfer between the Hβ 
protons of the coordinating cysteine residues and the bound 113Cd ions. The 113Cd 
chemical shifts in Fig 1.11B are reported relative to CdSO4. The 113Cd-HSQC spectrum 
consists of two horizontal lines of peaks, indicating that there are two chemically distinct 
Cd2+ ions present in the samples, with chemical shifts of 676.5 ppm and 695.0 ppm 
respectively. The coordinating protons have chemical shifts in the range 2.5-4.0 ppm, 
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which are characteristics of Cys Hβ protons. From knowledge of the chemical shifts 
assignments of the Cys resonances, it was deduced that the Cd at 695.0 ppm coordinates 
Cys 345,348,368 and 371, and therefore is identified as Cd I, while the Cd at 676.5 ppm 
coordinates Cys 360, 363, 382, and 385 and is identified as Cd II, indicating that Cd2+ 
/Zn2+ ions are coordinated in a cross-brace manner (Kellenberger et al., 2005). 
 
1.7.2 Replacement of Zn2+ by Cd2+ in the CNOT4 RING domain 
NOT4 is human protein forming part of the CCR-NOT complex, which plays a role in 
transcriptional regulation by interacting with RNA polymerase II.  Its N-terminal region 
contains a C4C4 RING finger, with a Cys-X2-Cys-X13-Cys-X-Cys-X4-Cys-X2-Cys-X(11-
16)-Cys-X2-Cys motif (Hanzawa et al., 2001; Albert et al., 2002). Although the CCR4-
NOT4 coordinates Zn2+ ions using a C4C4 motif, and the spacing observed between the 
fourth and the fifth coordinating residues is different from other C3HC4 RING fingers, 
(X4 rather X2-3), it nevertheless adopts the same topology (Hanzawa et al., 2001). 
 
Exchange of Zn2+ by Cd2+ was achieved by adding 113Cd-EDTA to a final concentration 
of 4 mM and monitored by 15N-HSQC spectra. Assignment of the Cd2+ -bound species 
was confirmed by 3D NOESY- (1H,15N)-HSQC and 3D TOCSY-(1H, 15N)-HSQC 
spectra. Large chemical shift differences were found for Cys17, Cys33 and Cys56 for 
both 1H and 15N chemical shifts (see Fig 1.12A). Other residues experienced smaller 
chemical shift changes, indicating that the exchange had no effect on the integrity of the 
whole structure (Hanzawa et al., 2001). 
 
 
 
 
 
 16
Zn2+ coordination was investigated using 113Cd-HSQC spectrum. As for the CNOT4 
RING finger, two chemically distinct Cd2+ resonances are observed with chemical shifts 
of 687.5 and 714.4 ppm respectively. The Cd at 687.5 ppm is coordinated to Cys14, 17, 
38 and 41, and the Cd at 714.4 ppm is coordinated to Cys33, 53, and 56 (see Fig 1.12B).  
Although the correlation of Cys31 with the Cd was not directly observed in the 113Cd-
HSQC spectrum it was taken to be the fourth residue coordinating Cd II on the basis of 
its conservation. With only this assumption the observed pattern agrees with the cross-
brace pattern observed for C3HC4 RING fingers (Hanzawa et al., 2001). 
 
1.7.3 Binding sites of Zn2+ and Cd2+ in cytochrome c 
Cytochrome c is one of a number proteins associated with the mitochondrial membrane, 
which mediate electron shuffling between ubiquinol-cytochrome c oxidoreductase and 
cytochrome c oxidase during respiration. Loss of Cytochrome c from the mitochondrial 
membrane leads to apoptosis. Binding of Zn2+ or Cd2+ is known to slow down the 
oxidative kinetics of Cytochrome c as monitored by H2O2 production. NMR was also 
used to monitor the binding of Zn2+ or Cd2+ ions (Gourion-Arsiquaud et al., 2005).   
 
Fig 1.13 shows the 15N-HSQC spectra obtained before (red) and after (black) the addition 
of Zn Acetate to the protein. Chemical shift changes induced by the exchange are shown 
in circles. Zn2+ binding residues include His33, Glu104, Ala103, Thr102, and Lys99. 
Glu104 experienced the largest shift, from which it was concluded that it is the major 
residue involved in Zn2+ coordination. (Gourion-Arsiquaud et al., 2005). 
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1.7.4 Kinetics of metal exchange and binding affinities 
RING finger domains coordinate two Zn2+ ions, but the strength with which the two ions 
are coordinated differs. The C3HC4 RING finger domains of LIM, BRCA1 and Hdm2 all 
show differences in the affinities of the two sites. The difference can be ascribed to a 
number of factors including: (1) differences in the chemical environment, (2) the 
structure and (3) the dynamical state of the two sites (Houben et al., 2005).  
 
RING finger domains from the p44 and the CNOT4 coordinate two Zn2+ ions using the 
C4C4 motif, however the exchange rate between the two sites and between the equivalent 
sites in the two proteins is different. Site 1 of CNOT4 protein exchanges the metal ion 
twice as fast as site 2, with the opposite being true in the case of p44. Both p44 
coordinating sites exchange faster than the CNOT4 sites.  
 
The differences in the exchange rates are influenced by the chemical nature of the two 
coordination sites.  Since Zn2+ and Cd2+ are positively charged they are exchanged faster 
in a negatively charged environment than in a positively charged environment. Site 2 of 
p44 is highly negatively charged and site 1 of CNOT4 is located close to negatively 
charged residues. In addition, site 2 of p44 is highly accessible to solvent, and surrounded 
by flexible residues which increases the likelihood of Zn2+ being exchanged faster than in 
CNOT4 (Houben et al., 2005).  
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1.9 Aims of the study 
Previous NMR analysis of a fragment of RBBP6 containing the RING finger domain 
have shown that the first 19 amino acids at the N-terminus are unstructured, which has 
hampered efforts to determine the structure of the domain. The aim of this study is to 
remove the unstructured residues, and then to use the shortened RING constructs to 
investigate the Zn2+ binding properties of the domain. This will be achieved by truncating 
the N-terminal region to produce constructs shortened by 13 and 19 amino acid residues 
respectively, expressed as GST-fusion proteins. After removal of the GST, 1D proton and 
15N-HSQC NMR spectra will be used to assess the folding and integrity of the shortened 
constructs, as well as the effect of lowering the pH below 6 (Zn2+ coordinating proteins 
tend to unfold in the vicinity of pH 5.5). 15N-HSQC and directly detected 113Cd spectra 
will be used to investigate whether Cd2+ ions can replace Zn2+ ions in proteins. 113Cd-1H-
HSQC spectra will be used in an attempt to observe magnetic correlation transfer 
between the 113Cd ions and protons in the side chains of the coordinating cysteine 
residues.   
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CHAPTER 2: Materials and methods 
 
2.1 Stock solutions buffers and bacterial strains 
All reagents were supplied by Promega, Bio-Rad, Merck Sigma, Roche, BDH, 
Invitrogen, Fermentas and Amersham Bioscience, unless otherwise stated. 
 
Ampicillin: 100 mg/ml stock solution prepared in distilled water. Stock solution diluted 
1:1000 in LB or agar media. 
APS (Ammonium persulphate): 10% APS prepared by dissolving 100 mg in 1 ml 
distilled water and stored at 4 oC. Solution stable for up to two weeks. 
5X Bradford reagent: 0.01% Coomasie Brilliant Blue G-250, 8.5% phosphoric acid, 
4.75% ethanol in water. 
113Cd-EDTA: 0.08 M stock solution prepared by dissolving 3.2 mg 113CdCl2 in 27.8 μl of 
0.5 M EDTA, and the volume made up to 174 μl with water.  
Chloramphenicol: 34 mg/ml stock solutions prepared in 100% ethanol. Stock diluted 
1:1000 in LB or agar media. 
Coomassie staining solution: 250 mg Coomassie Blue R-250, 45% methanol, and 10% 
acetic acid. 
Cleavage buffer: 0.05 M Tris-HCl, 0.15 M NaCl, 0.001 M EDTA, 0.001 M DTT, 1% 
Triton X 100, pH 7.0. 
Destaining solution: 5% methanol, 10% acetic acid in water. 
DNAse I buffer: 10X stock solution prepared by dissolving 0.1 M Tris pH 7.5, 0.025 M 
MgCl2, 0.005 M CaCl2. 
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DNA loading buffer: 0.25% Bromophenol Blue, 0.25% xylene cyanol, 30% glycerol in 
distilled water. 
 dNTPs: 100 µM  stock solution prepared in water. 
DTT (1,4-dithio-DL-threitol): 1M DTT stock solution prepared in 0.01 M sodium 
acetate pH 5.2, sterilized by filtration and stored at 4 oC.  
GTE (Glucose Tris EDTA): 0.025 M Tris-Cl pH 8.0, 0.01 M EDTA, and 0.05 M 
glucose, autoclaved and stored at 4 oC. 
IPTG (Isopropyl-1-thio- (D-galactoside): 0.1 M stock solution prepared by disolving 
1.19 g IPTG dissolved in 50 ml water. Solution divided into 5 ml aliquots, sterilized by 
filtration and stored at -20 oC. Stable for 2 to 4 months. 
Luria agar: 10 g tryptone powder, 5 g yeast extract, 5 g sodium chloride, and 2 g 
glucose, 15 g bacteriological agar, made up to 1000 ml with distilled water and 
autoclaved.  
Luria broth: 10 g tryptone powder, 5 g yeast extract, 5 g sodium chloride and 2 g 
glucose made up to 1000 ml with distilled water and autoclaved. 
Lysis Buffer: 50 μg/ml lysozyme, 35 mg/ml DNAse, 1% Triton X 100, 0.001 M DTT 
and 1X protease inhibitor cocktail in 1X PBS. 
Lysozyme: 50 mg/ml stock solution prepared in distilled water.  
M9 salts: 5X salts prepared by dissolving 64 g Na2HPO4.7H2O, 15 g KH2PO4, 2.5 g 
NaCl, 5.0 g NH4Cl made up to 1000 ml with water. Solution divided into 200 ml aliquots 
and autoclaved. 
M9 Minimal media: 200 ml 5X M9 salts, 2 ml 1 M MgSO4, 20 ml 20% Glucose, 0.1 ml 
1 M CaCl2, made up to 1000 ml with autoclaved distilled water. 
 
 
 
 
 21
NaOH/SDS/ lysis solution: 0.2 N NaOH, 1% SDS. 
PBS (Phosphate Buffered Saline): 10% stock solution prepared by dissolving 0.137 M 
NaCl, 0.0027 M KCl, 0.008 M Na2HPO4 and 0.0015 M KH2PO4 pH 7.4. 
NMR buffer: 0.05 M Sodium phosphate pH 6.0, 0.15 M NaCl, 0.001 M DTT, 0.001 M 
EDTA and 0.02% NaA3.  
Neutralization solution: 3 M potassium acetate prepared in water. pH adjusted to 4.8 
using acetic acid and stored at room temperature.  
Phenol/chloroform/isoamylalcohol: 25 parts Tris saturated phenol: 24 parts chloroform 
and 1 part isoamyl-alcohol and stored at 4 oC. 
Primers: 100 μM stock solutions stored at -20 oC. 
Protein elution buffer: 0.01 M glutathione and 0.05 M Tris, pH 8.0. 
 RNAse (DNAse free): 100 mg/ml stock solution prepared in 0.1 M Sodium acetate and 
0.0003 M EDTA pH 4.8. Solution boiled for 15 minutes and cooled quickly by placing it 
on ice. Stored at -20 oC. 
SDS: 10% stock solution prepared by dissolving 100 g of SDS was dissolved in 900 ml 
water, heated to 68 oC to dissolve the crystals, and the volume made up to 1000 ml. 
Stored at room temperature.  
2X SDS sample buffer: 4% SDS, 0.125 M Tris pH 6.8, 15% glycerol and 1 mg/ml 
Bromophenol Blue. Stored at room temperature. 0.2 M DTT added to the buffer 
immediately prior to use. 
Electrophoresis buffer: 10% stock solution prepared by dissolving 30 g Tris-Cl, 144 g 
Glycine, 10 g SDS, made up to 1000 ml with distilled water. 
Separating buffer: 1.5 M Tris pH 8.8, stored at 4 oC. 
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Sodium azide: 10% stock solution prepared by dissolving 10 g in 100 ml distilled water. 
Stacking buffer: 0.5 M Tris pH 6.8, stored at 4 oC. 
TBE: 10X stock solution prepared by dissolving 108 g Tris, 55 g boric acid, and 9.3 g 
EDTA, made up to 1000 ml with distilled water. 
TBS-T: 17.532 g NaCl, 6.057 g Tris, 0.1% Tween 20, pH 7.5, made up to 2000 ml with 
distilled water. 
Tris-Cl: 1 M stock solution prepared by dissolving 121.4 g in 500 ml of distilled water, 
pH adjusted with HCl and the volume made up to 100 ml.  
TE: 10X stock solution prepared from 0.1 M Tris-Cl and 0.01 M EDTA. 
Bacterial strains: E. coli BL21 (DE) pLys cells for protein expression and E.coli 
MC1061 competent cells for DNA manipulation. 
 
 
2.2 Generation of DNA expression constructs 
2.2.1 Primer design 
PCR primers were designed based on the human RBBP6 gene mRNA isoform sequence 
(Accession number NP_008841 (protein sequence); NM_006910 (nucleotide sequence)). 
Both forward primers included Bam HI restriction sites while the reverse primer included 
an Xho I site for cloning into the Bam HI and the Xho I sites of the pGEX-6P-2 vector. 
Two stop codons, TTA and TCA, (see Table 3.1) were included in the reverse primer. 
 
 
2.2.2 PCR amplification  
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PCR amplifications were carried out in reactions containing 1 X PCR reaction buffer, 1 
μl of 10 pM primers, 1 μl of 5 mM dNTPs, and 0.5 μl of 0.5 U/μl Taq polymerase. 0.75 
μl of 50 mM MgCl2 was added to the reaction mixture and finally 1μl of the template 
pGEX-6p-2-RING was added. The final volume was made up to 25 μl with sterile 
autoclaved water. The PCR tubes were briefly centrifuged and the amplification carried 
out under the following conditions: 
94 oC for 2 mins to denature the double stranded DNA, followed by 35 cycles each 
consisting of the following steps: 94 oC for 1 min to denature the double stranded DNA, 
62 oC for 1 min to anneal the double strands, 72 oC for 1 min to extend the DNA. The 
final step consisted of holding the tubes at 72 oC for 10 mins. The products were analysed 
on 1% agarose gels as described in Section 2.2. 
 
2.2.3 Colony PCR assay 
Colony PCR was used to screen transformed colonies for the presence of insert. 
Following transformation, single colonies were picked and re-suspended in 20 μl of 
distilled water. 1 μl of each suspension was added to the PCR reaction in place of the 
DNA template and the reaction carried out as described in Section 2.2.2. Where the 
cloning was into pGEM-T Easy vector, M13 primers with an annealing temperature of 55 
oC were used; for cloning into pGEX-6P-2 vector, the primers used for the original 
amplification were used at an annealing temperature of 62 oC.  
 
2.2.4 Cloning of PCR products and restriction fragments  
PCR products were diluted 1:100 with sterile distilled water and cloned into the pGEM-T 
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Easy vector (Promega). Ligation reactions were set up as shown in Table 2.1. The 
ligation reactions were incubated at 4 oC for 16 hours. 10 μl of each ligation mixture was 
used to transform E.coli MC1061 competent cells, as described in Section 2.2.8. DNA 
restriction fragments (Section 2.1.5) were purified using the GFX kit (Amersham 
Bioscience: GE Healthcare, GFX PCR DNA and Gel Band purification kit) according to 
the manufacture’s instructions and cloned into the pGEX-6P-2 expression vector. 
Ligation reactions were set up as shown in Table 2.2. The samples were briefly mixed 
and incubated at room temperature for 3 hours. 10 µl of the ligation product was used to 
transform BL21 and MC1061 competent cells as described in Section 2.2.8. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.1 Experimental setup for cloning PCR products into pGEM-T Easy 
vector 
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Tubes (1.5ml) Positive 
control 
Negative 
control 
Experimental 
reaction 
Reagents final 
concentration 
pGEM-T Easy 
(5 ng/μl) 
1 μl 1 μl 1 μl pGEM-T Easy 
(0.25 ng/μl) 
PCR products 0 µl 0 µl 1 μl PCR products 
Control insert 
(4 ng/μl) 
2 μl 0 µl 0 µl Control insert 
(0.4 ng/μl) 
2x Rapid Ligation 
buffer 
2 μl 2 μl 2 μl 1x Rapid Ligation 
buffer 
T4 DNA Ligase 
(3 units/μl) 
1 μl 1 μl 1 μl T4 DNA Ligase 
(0.15 units/20 μl) 
dH2O 14μl 16 μl 15μl  
Total volume (μl) 20 μl 20 μl 20 μl  
 
 
Table 2.2 Ligation reactions for cloning DNA fragments into pGEX-6P-2 expression vector 
 
Experimental tubes 
with reagents 
Negative control 
(Background) 
Standard reaction 
Vector (pGEX-6P-2) 1 µl 1 µl 
PCR products 0 µl 3 µl 
2X ligation buffer 2 µl 2 µl 
T4 DNA Ligase 
(3 units/µl) 
1 µl 1 µl 
dH2O 16 µl 13 µl 
Total volume (µl) 20 µl 20 µl 
 
2.2.5 Restriction digestion 
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Restriction double digests were designed using the Fermentas double digest online server 
(www.fermentas .com/double digest/) as shown in Table 2.3. The reagents were mixed in 
a 1.5 ml microfuge tube and incubated at 37 oC for 1.5 hours. The samples were analysed 
by electrophoresis on a 1% agarose gel. The fragment corresponding to the insert was 
purified from the gel using the GFX kit (Amersham Bioscience: GE Healthcare, GFX 
PCR DNA and Gel Band purification kit) according to the manufacture’s instructions. 
 
 
Table 2.3 Experimental set up for restriction double digests of pGEM-T Easy and pGEX-6P-2 vector. 
Reagents Volume (µl) 
Vector  25 µl 
2X Tango TM buffer 20 µl 
Bam HI 3 µl 
Xho I 1 µl 
dH2O 1 µl 
Total volume 50 µl 
  
2.2.6 DNA Sequencing 
Plates containing single colonies were sent for sequencing at Inqaba Biotechnical 
Industries (Pty) Ltd. Sequences were compared with the expected sequences using the Bl-
ast 2 sequence alignment tool (http://www.ncbi.nlm.nih.gov/BLAST/bl2seq/wblast2.cgi (
Tatusova and Madden,1999)). Translations into protein sequences were carried out using 
the EXPASY Translate Tool (http://au.expasy.org/tools/dna.html). Validation of the base 
calling was performed by inspection of the raw sequencing trace, using the Finch TV 
software suite (http://www.geospiza.com/finchtv). 
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2.2.7 Plasmid DNA isolation 
Small scale plasmid DNA isolation was performed using the alkaline lysis method 
(Birnboim and Doly, 1979). A single colony was used to inoculate 15 ml Luria-Bertani 
broth containing 100 µg/ml ampicillin and incubated overnight at 37 ºC with shaking. 
From the overnight culture 900 µl was added to 100 µl of sterile glycerol for storage at    
-70 oC. The remaining cell suspension was centrifuged at 5520 xg for 10 min and the 
supernatant discarded. The pellet was re-suspended in 200 µl GTE and incubated on ice 
for 5 min.  400 µl lysis solution was added to the cell suspension, the mixture was mixed 
gently and incubated on ice for 5 mins. 300 µl of neutralising solution was added, mixed 
gently and the solution incubated on ice for 5 mins.  
 
The flocculent was precipitated by centrifugation at 5520 xg for 15 mins. 800 µl of the 
supernatant was transferred into a fresh tube, 600 µl of isopropanol was added, mixed by 
vortexing and incubated at –20 ºC for 1 hour. The sample was then centrifuged for 10 
mins at 9.3 xg, the supernatant discarded and the pellet washed twice with 70% ethanol. 
The pellet was air-dried and re-suspended in 50 µl of 1X TE. 5 µl of 10 mg/ml RNAse A 
was added and the sample incubated at 37 oC for 1 hour. Equal volume of 25 parts 
phenol: 24 parts chloroform: 1 part isoamyl-alcohol was added to the mixture and the 
tube was centrifuged for 5 mins at 9.3 xg. 
 
The supernatant was transferred into a fresh tube and 0.1 volumes of 7 M sodium acetate 
pH 5.2 and 2.5 volumes ice-cold 100% ethanol added onto the samples. The samples 
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were incubated at –20 ºC for 30 mins and centrifuged for 10 mins at 9.3 xg. The 
supernatant was discarded and the pellet was washed with 70% ethanol. The sample was 
centrifuged for 10 mins at 9.3 xg and the supernatant discarded. The pellet was allowed 
to dry on a paper towel and re-suspended in 50 µl 1X TE. The DNA was stored at 4 ºC 
for future use. 
 
2.2.8 Transformation of plasmid DNA into competent cells 
Competent cells, which were prepared by Mr A. Faro, Department of Biotechnology, 
UWC, were thawed on ice for 5 mins. 10 µl ligation mixture or plasmid DNA was added 
to 50 µl of competent cells and the cells incubated on ice for 30 mins. The cells were 
heat-shocked at 42 oC for 45 s and incubated on ice for a further 5 mins. 900 µl of 
prewarmed LB was added and the tubes were incubated at 37 oC for 1 hour with shaking. 
100 µl of the culture was plated on LB agar plates containing 100 µg/ml ampicillin and 
incubated at 37 oC overnight. 
 
2.3 Expression and purification of the recombinant protein 
2.3.1 Small-scale protein expression screen 
Single colonies of E.coli BL21 cells transformed with expression vector were picked, 
inoculated in 6 ml LB containing 100 μg/ml ampicillin and incubated at 37 oC with 
shaking. After four hours two samples of 2 ml each were transferred into fresh tubes, and 
IPTG added to a final concentration of 0.1 mM (induced samples). Nothing was added to 
the remaining 2 ml sample (uninduced sample). Both the induced and the uninduced 
cultures were incubated at 37 oC for a further 3 hours. The cells were harvested by 
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centrifugation at 15.7 xg for 10 mins. 40 μl of sample buffer was added to both the 
induced and the uninduced pellet and the protein was analysed on a 16% SDS PAGE gel 
(Section 2.5).  
 
2.3.2 Large-scale expression of recombinant protein 
Single colonies of E.coli BL21 cells transformed with expression plasmids were 
inoculated into 6 ml LB containing 100 µg/ml ampicillin and 34 µg/ml chloramphenicol 
and incubated at 37 oC with shaking. After 4 hours, 2 ml was used to inoculate 100 ml of 
either enriched media (LB) containing 100 µg/ml ampicillin and 34 µg/ml 
chloramphenicol. For 15N-labelling, proteins were expressed in minimal media in which 
NH4Cl in M9 salts was substituted by 15NH4Cl. The culture was incubated at 37 oC 
overnight with shaking. The following morning the overnight culture was scaled-up to 
1000 ml by addition of 900 ml media containing the same concentration of antibiotics 
and incubated at 37 oC for six hours with shaking until the optical density at 550 nm 
reached between 0.4 and 0.6.  
 
One hour prior to induction 100 μM ZnSO4 was added for proper folding of the protein. 
Induction was carried out at 25 oC for 16 hours by addition of IPTG to a final 
concentration of 0.7 mM. Following induction the bacterial cells were recovered by 
centrifugation at 5000 g for 10 mins at 4 oC and the pellets stored at -20 oC until needed. 
After freezing the pellet was re-suspended in 20-25 ml lysis buffer. Lysis was carried out 
in three successive cycles of freezing at -70 oC for 5 mins, followed by thawing at 37 oC 
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for 5 mins. 0.02% of sodium azide was added to inhibit bacterial growth and the lystate 
was held at 4 oC until further purification. 
 
2.3.3 Glutathione affinity purification of GST-fusion proteins  
10 ml glutathione agarose beads were prepared by mixing 700 mg lyophilized beads with 
distilled water, and leaving it to swell overnight at 4 oC. After swelling the agarose beads 
were poured into a 20 ml disposable plastic column and washed thoroughly with 
equilibration buffer (PBS) to remove traces of lactose present in the lyophilized beads. 
For long-term storage the beads were stored at 4 oC in 1 M NaCl and 1 mM sodium 
azide. Prior to each purification, the column was washed with 3 column volumes (CV) of 
2 M NaCl and equilibrated with 5 CV of 1 X PBS. 10 ml of the protein sample was added 
to the column and the flow through collected. The column was then washed with 5 CV of 
PBS containing 1% Triton X100 and the flow through collected. To elute retained fusion 
protein, 1 CV of elution buffer containing 10 mM glutathione in 50 mM Tris pH 9.5 was 
added to the column and the flow through collected in 10 ml fractions. Finally the column 
was washed with 5 CV of 2 M NaCl.  
 
2.3.4 Cleavage of the GST-fusion proteins using 3C protease 
3C protease from human rhinovirus (HRV 3C), recombinantly expressed as a GST-fusion 
protein, was a kind gift of James Ezenwa Onyemata in the Department of Biotechnology, 
UWC. 40 μl 3C protease, 0.001 M EDTA, 0.001 M DTT and 1% TRITON X100 were 
added to the recombinant protein which was transferred to dialysis tubing (MWCO 
3500Da) and placed in 2000 ml cleavage buffer and incubated overnight at 4 oC with 
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stirring following cleavage, the target protein was separated from GST in a second round 
of glutathione affinity purification (see Section 2.3.3), with the target protein remaining 
in the flow through and GST and 3C protease being retained on the column. 
 
2.3.5 Anion exchange chromatography 
Anion ion exchange chromatography was carried out using a 1.6 ml column containing 
20HQ POROS media (Amersham Bioscience) on a BioCad SprintTM perfusion 
chromatography system (Perspective Biosystems). The buffer used was 50 mM Tris-Cl, 
pH 7.0 flowing at a rate of 10 ml/min. The instrument was operated using a pre-
programmed sequence comprising of a 10 column volumes (CV) equilibration step, 
followed by injection of the sample, followed by 10 CV wash step, followed by a 0-0.5 
M NaCl gradient spanning 15 CV, followed by a final wash step consisting of 5 CV of 2 
M NaCl. Eluted proteins were monitored using A280 using an in-time UV detector and the 
NaCl concentration was monitored using an in-time conductivity meter. 1 ml fractions 
were collected using a GILSON® FC-203B automated fraction collector and the 
presence of eluted proteins was confirmed by analysing fractions on SDS-PAGE gel. 
 
2.3.6 Size exclusion chromatography  
Final purification (removal of residual GST) was performed using a 150 ml Sephacryl 
S100 column (Amersham Pharmacia Biotech) operated manually using a BioCad Sprint 
Perfusion chromatography system. The column was equilibrated with 1.5 CV of NMR 
buffer at a flow rate of 1.5 ml/min. Protein samples were concentrated to 1 ml using Viva 
Spin ultra-filtration devices (MWCO 3500 Da, Satorius Stedim Biotech S.A) and injected 
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into a 1 ml sample loop using a Hamilton 1 ml syringe. Fractions were collected using a 
GILSON® FC-203B automated fraction collector and the presence of eluted proteins was 
confirmed by analysing on SDS-PAGE gel. 
 
2.4 Agarose gel electrophoresis of DNA  
DNA was analysed by electrophoresis on 1% agarose gels.  Gels were prepared by 
adding the required volume of 1 X TBE to the appropriate mass of electrophoresis grade 
agarose. The agarose was boiled and cooled to 55 oC followed by the addition of 
ethidium bromide to a final concentration of 0.5 µg/ml and poured onto a gel casting 
device. 0.5 μl of loading buffer was mixed with 5-20 µl of the DNA and loaded onto the 
gel. The marker was loaded in the first lane to show the sizes of the bands. The DNA was 
visualised by placing the gel under UV light and photographed using a ChemiDoc XRS 
Imager System (Bio-Rad Laboratories, Inc). 
 
2.5 SDS-PAGE gel electrophoresis 
Proteins were analysed by electrophoresis on 16% poylacrylamide gels using Laemmli’s 
method (Laemmli, 1970). The separating gel was prepared from 8 ml 40% 37:5:1 
polyacrylamide, 0.12 ml 10% APS, 0.21 ml 10% SDS, 5.25 ml separating buffer, 0.021 
ml TEMED and the volume was made up to 20 ml using distilled water. The stacking gel 
was prepared from 1.5 ml 40% 37:5:1 polyacrylamide, 0.05 ml 10% APS, 0.1 ml 10% 
SDS, 2.5 ml stacking buffer, 0.02 ml TEMED and the volume was made up to 10 ml 
using distilled water.  
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Samples were mixed with equal volumes of 2X SDS sample buffer, incubated in a heat 
block at 100 oC for 10 mins and centrifuged for 10 mins at 9.3 xg. The samples were then 
electrophoresed at 10 V/cm using a Hoefer Mighty Small II gel electrophoresis system. 
Once the dye front had reached the end of the gel, the gel was removed from the caster 
and incubated in Coomassie staining solution for 30 mins. Thereafter it was transferred 
into Destaining solution until the background was clear. 
 
 2.6 Bradford Assay 
Protein concentrations were determined using the Bradford Assay, using BSA (Bovine 
Serum Assay) as the standard. From a stock solution of 1 mg/ml BSA, a series of 
dilutions was made in the range 10 μg/ml to 50 μg/ml, using the same buffer as in the 
sample to be tested. The sample to be tested was diluted 1:1000 and 1:2000 dilutions, 200 
μl of both dilutions of the sample and each dilution of the standard were added in 
duplicate to cuvettes. 200 μl of buffer was added in duplicate to serve as blank. The 5X 
Bradford Reagent was diluted in a 1:5 dilution in water and 1800 μl added to each 
cuvette. The samples were allowed to stand for 5 mins at room temperature. The 
absorbance was measured at 595 nm using the spectrophotometer. The average of each 
pair of duplicates were calculated and the standard curve plotted using Microsoft Excel. 
The absorbance at 280 nm (A280) was measured using a NanoDrop ® ND 1000 
spectrophotometer (Nano Drop technologies, Inc). A sample of 2 μl was used for each 
measurement.  The spectrophotometer was calibrated using the same buffer as in the 
sample to be measured.  
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2.7 NMR analysis and characterisation of Zn2+ binding  
2.7.1 Sample preparation 
Samples were concentrated to 600 μl (2.805 mM) using Viva spin ultra-filtrtation devices 
(MWCO 3500 Da, Sartorius Stedim Biotech S.A) and 7% D2O was used to act as a lock 
signal. Efficient suppression of the water resonance at 4.73 ppm was achieved using pre-
saturation. NMR analysis was carried out in H2O rather than D2O because exchange of 
the labile amide protons would have resulted in suppression of their NMR resonances, 
which are required for 15N-HSQC experiments 
 
2.7.2 NMR data collection and processing 
All NMR spectra were recorded at 25 oC on the Varian Unity Inova 600 MHz 
spectroscopy in the Department of Chemistry at the University of Stellenbosch. Spectra 
were processed using NMRPipe (Delaglio et al., 1995) and analysed using NMRView 
(Johnson, 2004). 
 
2.7.3 Replacement of Zn2+ by 113Cd2+  
50 μl of 50 mM 113Cd-EDTA was added to a 0.5 mM 15N-labelled protein sample, to a 
final concentration of 4 mM. The replacement of Zn2+ by Cd2+ was conducted by 
observing its effect on the 15N-HSQC spectrum of the protein.  
2.7.4 pH sensitivity measurements 
A series of NMR buffers was prepared with pH values 6.0, 5.8, 5.6, 5.4 and 5.2 
respectively. A 600 μl NMR sample containing approximately 0.5 mM protein was 
dialysed against a 10-fold diluted NMR buffer and then 100 μl was added to 500 μl of 
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each buffer in the pH series, to produce five separate samples of 600 μl each. Each 
sample was transferred to a separate NMR buffer. 7% D2O was added to serve as lock 
signal. 
 
2.7.5 Prediction of protein parameters 
Prediction of protein molecular weights, pI and nitrogen content were made using the 
online server Expasy Translate Tool (http://au.expasy.org/cgi-bin/protparam), see 
Appendix IV. 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 3: Recombinant expression and purification of shortened 
RING finger domains 
 
 
 
 
 
 36
Previous analysis of a fragment of human RBBP6 containing the RING finger domain 
using NMR showed that the first 19 amino acids at the N-terminus were unfolded. 
Multiple resonances resulting from the structural heterogeneity of these residues led to 
obscuring of a number of structurally important resonances, hampering efforts to 
determine the structure of the domain. The aim of the work described in this chapter was 
to remove this unstructured region and produce two constructs shortened by 13 and 19 
amino acid respectively. The constructs will be referred to as RING_sl (“RING_short-
long”) and RING_ss (“RING_short-short”) respectively. 
 
The two constructs were expressed as GST fusion proteins, using the pGEX-6P-2 vector 
system (Amersham Pharmacia Bioscience). The pGEX-6P-2 expression vector contains a 
tac promoter, which under IPTG induction drives the expression of recombinant proteins 
at high levels. The GST tag allows for affinity purification using a glutathione agarose 
column as well as improving the solubility of the target protein. The recognition site for 
3C protease allows for separation of the target protein from GST. The expected amino 
acid sequences of the two shortened constructs following removal of GST is a domain 
shown in Appendix I. 
 
  
3.1 Cloning of shortened RING constructs into the pGEX-6P-2 expression vector 
3.1.1 PCR amplification of RING finger domains 
Two new forward primers were synthesized to shorten the previous construct by 13 and 
19 amino acids, respectively (see Fig 3.1). The reverse primer was the same as used 
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previously. Both forward primers incorporated Bam HI restriction sites and the reverse 
primer incorporated an Xho I restriction site. Both fragments were amplified by PCR 
using the original RING construct as a template, as described in Section 2.2.2. Fig 3.2 
shows that both RING_sl and RING_ss fragments were successfully amplified. 
 
3.1.2 Cloning of RING fragments into the pGEM-T Easy vector 
The PCR products were cloned into the pGEM-T Easy TA cloning vector and 
transformed into competent E.coli MC1061 cells as described in Chapter 2. Five colonies 
were picked for each RING construct and a colony PCR using M13 primers was used to 
screen for recombinant colonies. The expected sizes of positive clones are 461 bp and 
443 bp for RING_sl and RING_ss respectively, corresponding to the insert flanked by 
100 bp on both ends. Positive clones for RING_sl can be seen in lanes 3,4 and 6 of Fig 
3.3; a single positive clone for RING_ss appears in lane 8.  
 
One colony from each of the positive clones was inoculated into enriched media for small 
scale DNA isolation as described in Section 2.3.7, and plasmid DNA was digested with 
Bam HI and Xho I to release the insert. The appearance of a fragment of the expected size 
(~261 bp) in lane 4 of Fig 3.4 shows that RING_sl was successfully cloned. The absence 
of similar fragments in lane 2 shows that cloning of the RING_ss was unsuccessful. The 
RING_sl restriction fragment was purified from the gel and cloned into the pGEX-6P-2 
expression vector. Plasmid DNA was isolated as described in Section 2.3.7 and digested 
with Bam HI and Xho I to release the insert. Positive clones can be seen in lanes 2 to 4 
and 6 of Fig 3.5.  
 
 
 
 
 38
 
Since cloning the RING_ss into pGEM-T Easy was unsuccessful , the PCR fragment was 
cloned directly into the pGEX-6P-2 expression vector. PCR amplified fragments were 
digested using Bam HI and Xho I restriction endonucleases, gel-purified using the GFX 
kit and cloned directly into pGEX-6P-2 expression vector. Isolation of plasmid DNA 
followed by digestion with Bam HI and Xho I restriction endonucleases revealed the 
presence of four positive clones (data not shown) 
 
3.1.3 DNA sequencing 
Four RING_sl and four RING_ss clones were sequenced. The sequences of both 
RING_sl and four RING_ss determined and analysed as described in Section 2.2.6. All 
RING_sl sequences were found to contain the same single mutation at position 219 of the 
query sequence. However, it is a silent mutation, since it replaces CAG with CAA, both 
of which code for glutamine (Q). The other mutation, which appears at position 235 of 
the 3’ amplified sequence, was found to be a base-calling error on inspection of the 
sequencing trace (see Appendix II). All RING_ss sequences were 100% correct (see 
Appendix III).  
 
3.2 Expression and affinity purification of GST-RING_sl and GST-RING_ss  
GST-RING_sl and GST-RING_ss plasmid constructs were transformed into E.coli BL21 
competent cells and screened for expression using small-scale expression screen 
described in Section 2.3.1 Both GST-RING_sl (see Fig 3.6) and GST-RING_ss showed 
good expression relative to the uninduced samples. Large-scale expression and extraction 
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(Section 2.3.2) showed that both proteins were expressed at high levels in enriched media 
and were both found in the soluble fractions following extraction.  
 
When expressed in minimal media, most of the protein was found in the insoluble 
fraction. However when the minimal media was supplemented with 100 μM ZnSO4, the 
protein was once again found at high levels in the soluble fractions. Fusion proteins were 
separated from cellular proteins using glutathione affinity chromatography as described 
in Section 2.3.3 Lanes 6 and 7 of Fig 3.7A provide an indication of the high levels of 
recovery of GST-RING_sl following affinity purification. 
 
3.3 Cleavage of GST-RING_sl and GST-RING_ss and removal of GST by affinity 
chromatography 
Affinity purified GST-RING_sl and GST-RING_ss samples were cleaved using 3C 
protease, and the GST was removed in a second round of glutathione agarose affinity 
purification. GST, GST-3C and uncleaved GST-RING were all retained by the column 
(free glutathione from the previous affinity step having been removed by dialysis prior to 
3C cleavage), whereas RING_sl was collected in the flow through. As it can be seen from 
lanes 2-4 in Fig 3.7B RING_sl appears to be dimeric when visualised on SDS PAGE gel, 
something, which was also characteristic of the previous RING construct. RING_ss 
sometimes appears to be dimeric, sometimes monomeric (data not shown). 
 
3.4 Final purification of RING_sl and RING_ss  
3.4.1 Anion-exchange chromatography  
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Since the pI of GST and RING_sl are 5.0 and 4.7 respectively as determined by the 
Expasy server http://www.expasy.org/tools/protparam.html), it would be expected that 
both proteins would be strongly retained on an anion exchange column at pH 7.0, with 
RING_sl being slightly more strongly retained. A partially purified sample of RING_sl 
containing a small amount of GST was loaded onto the anion exchange column and 
eluted with a gradient of 0-0.5 M NaCl. The chromatogram in Fig 3.8A shows that both 
proteins were retained and that a clear separation was achieved between them with, 
surprisingly, RING_sl eluting near the beginning of the gradient (peak 2) and GST near 
the end (peak 3). From the apparent molecular weights it is clear that RING_sl elutes in 
Peak 2 (lane 2) and GST in Peak 3 (lane 5). These conclusions were confirmed by the 
SDS PAGE gel shown in Fig 3.8B. Fractions corresponding to peak 2 were pooled and 
concentrated to 1 ml using Viva spin ultra-filtrtation devices (MWCO 3500 Da, Sartorius 
Stedim Biotech S.A). 
 
3.4.2 Size exclusion chromatography  
Size exclusion chromatography using a 150 ml Sephacryl S100 column was used to 
remove residual GST and other contaminants, at the same time as exchanging the protein 
into NMR buffer. A clear separation between GST (Peak 1) and RING_sl  (Peak 2) can 
be seen in Fig 3.8A, where the identities of the protein in each peak are confirmed by 
SDS PAGE gel analysis shown in Fig 3.9B.  GST elutes earlier than RING_sl, as 
expected since it has a larger molecular weight than RING_sl (26.6 kD as opposed to 
10.2296 kD). Similar results obtained for RING_ss are shown in Fig 3.10. Comparison of 
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Fig 3.9 and Fig 3.10 shows that RING_ss appears to be monomeric, whereas RING_sl 
appears to be dimeric, despite the fact that samples contained 1 mM DTT. 
 
3.5 Determination of Protein concentration 
After the final purification by size exclusion chromatography, fractions corresponding to 
RING_sl were pooled and concentrated down to a final volume of 600 µl using Viva Spin 
Ultra filtration devices (MWCO 3500 Da, Sartorius Stedim Biotech S.A). The concentrat-
ed RING_sl sample is shown in Fig 3.11, where the extensive overloading shows that the 
protein is highly concentrated. 5 mM DTT was added to prevent the formation of inter-
molecular disulphides bonds. 
 
The final concentration of the RING_sl was determined using the Bradford Assay. 
Samples were prepared as described in Section 2.6 and absorbance readings at dilution 
factors of 1:1000 and 1:2000 were recorded at 595 nm. The absorbance readings (Table 
3.1) for BSA were used to construct a standard curve (Fig 3.12) from which the 
concentration of RING_sl was determined. At 1:1000 dilution the absorbance of RING_sl 
was found to be 0.4685 (Table 3.1), which, using the standard curve, corresponds to 
~28.6 μg/ml, from which the original concentration was calculated to be:  
                                              
C =28.6 μg/ml * 1000 
= 28.6 mg/ml 
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At 1:2000 dilution the absorbance was found to be 0.237 (Table 3.1), which, using the 
standard curve corresponds to ~14.5 μg/ml, from which the original concentration was 
calculated to be:  
C = 14.5 μg/ml * 2000 
= 28.9 mg/ml 
Since the molecular weight of RING_sl is 10.2296 kD these correspond to molar 
concentrations of 2.79 mM and 2.82 mM respectively. We took the average of the two 
values, giving the concentration as 2.81 mM. 
    
3.6 Calculation of the molar extinction coefficient  
The absorbance at 280 nm (A280) of the final NMR sample was determined using a 
NanoDrop® ND-1000 spectrophotometer (NanoDrop technologies Inc) and found to be 
9.14 (see Fig 3.12). Note that the Nanodrop automatically adjust the optical path length 
so that the absorbance is within the linear range. However the output results is scaled so 
that it corresponds to as optical path length of 1cm. Using the Beer Lambert Law: 
 
                                                  A280 = εCl 
And using the values A280 = 9.14, C = 0.002805 M and L = 1 cm (the optical path length), 
the molar extinction coefficient is calculated to be: 
 
 
 
         ε  =  A280 / CL 
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=9.14/(1cm*0.002805 M) 
        = 3258 M-1 cm-1 
This value can be compared to the extinction coefficient predicted by Expasy server at 
http://www.expasy.org/tools/protparam.html, which is 2980 M-1cm-1. The theoretical 
value was calculated by assuming that no cys residues appear as half cys, since 5 mM 
DTT was added to the final sample to reduce the disulphide bridges. Considering that 
RING_sl contains no Tryptophan residues which are the basis for the prediction, a 10% 
discrepancy between the observed and the predicted values of ε is probably within 
experimental errors. 
 
 
 
 
 
 
 
 
  
 
 
 
Chapter 4: NMR analysis of Zn2+ coordination by the RBBP6 RING 
domain 
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4.1 Preliminary NMR analysis 
Unlabelled and 15N-labelled samples of RING_sl and RING_ss were produced as 
described in Chapter 3, and used to investigate the state of folding of both shortened 
domains using NMR. Chemical shifts of folded proteins are well dispersed relative to 
unfolded protein due to the presence of different chemical environments and shielding 
effects, particularly from the ring currents caused by aromatic side chains (Rehm et al., 
2002). The 1 dimensional (1D) spectrum of RING_sl shown in Fig 4.1A reveals that the 
protein is well folded, as indicated by the number of resonances that are shifted up-field 
into the region 8.5-10 ppm and down field into the region 0-1 ppm.  
 
The 1D spectrum of the RING_ss shown in Fig 4.1B reveal that the protein is unfolded, 
as indicated by poorly dispersed amide backbone chemical shifts of the protons. The 
clustering of backbone HN resonances around 8.3 ppm and poor dispersion of the 
resonances in the aliphatic region between 1.0 and -1.0 (Rehm et al., 2002) also indicate 
that RING_ss is unfolded. To further confirm the folding and integrity of the two 
shortened RING constructs, 15N-heteronuclear single quantum coherence spectra 15N-
HSQC were recorded. In a 15N-HSQC spectrum each peak corresponds to the backbone 
NH group of a single amino acid, with the horizontal coordinate corresponding to the HN 
chemical shift and the vertical coordinate corresponding to the chemical shift of the 
attached nitrogen. Exceptions are the pairs of peaks that correspond to side chain NH2 
groups of arginine and glutamine residues, which are found at the top right hand corner of 
the spectrum. Proline residues do not appear in the 15N-HSQC spectrum, because they 
lack NH groups (Rehm et al., 2002). 
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The 15N-HSQC spectrum shown in Fig 4.2A confirms that RING_sl is folded as it is 
characterized by more peaks, which are well dispersed in both dimensions (Larsson et al., 
2003; Woestenenk et al., 2003). In the 1H dimension a number of resonances are shifted 
up field into the region to the left of 8.5 ppm. The resonances are very sharp, indicating 
that the protein tumbles rapidly in solution, which suggests that the protein adopts a 
globular shape. Unfolded proteins, on the other hand have broad lines as result of 
aggregation. The signals cluster around the 1H frequency of 8.3 ppm with little dispersion 
to either sides. The 15N-HSQC in Fig 4.2B confirms that RING_ss is unfolded (Larsson et 
al., 2003).   
 
Fig 4.3 shows that the 15N-HSQC spectrum of RING_sl (black) superimposes very well 
over that of the previous RING construct. We conclude from this that RING_sl adopts 
essentially the same structure as that of the previous RING construct, with the exception 
of the unstructured N-terminal amino acids. The RING_ss domain, on the other hand, is 
clearly unstructured and no further analysis of it was undertaken. 
 
 
4.2 Investigation of Zn2+ binding using mass spectrometry  
One of the primary aims of this work was to determine whether Zn2+ was required for the 
folding of the RBBP6 RING domain. The fact that protein expressed in the absence of 
Zn2+ (minimal media with no added Zn2+) was predominantly insoluble whereas 
expression of protein in the presence of Zn2+ is soluble, suggested that Zn2+ was required.  
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In order to confirm this we first used mass spectrometry to investigate the mass of the 
protein. In the absence of Zn2+ ions RING_sl is expected to have a molecular weight of 
10229.6 Da as determined by the on-line EXPASY server. However, since the sample 
was enriched with 15N, and each molecule contained 122 nitrogen atoms, the size of the 
protein was expected to increase by 122 Da, giving an expected size of 10351.6 Da. Since 
the molecular weight of a single Zn2+ ion is 65.409 Da, with one Zn2+ bound the mass of 
the protein was expected to be 10417.009 Da, whereas with two ions bound it was 
expected to be 10482.418 Da. The mass found using Electro-spray mass spectrometry 
(see Fig 4.4) was 10349.0010 Da, from which we concluded that despite the use of mild 
conditions, no Zn2+ ion remained bound to the protein.  
 
4.3 Investigation of Zn2+ binding using NMR 
Cd2+ is known to replace Zn2+ in a number of proteins, with only minor effects on the 
structure of the protein (Hanzawa et al., 2001; Houben et al., 2005), However 
replacement leads to perturbation of the 15N-HSQC spectrum of the proteins which 
therefore provides a convenient means of interpreting the exchange. Initially 
investigation of Zn2+ exchange by Cd2+ was unsuccessful, and no exchange was observed. 
 
 
 
 4.3.1 pH sensitivity measurements 
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Since the attempt to observe Cd2+ /Zn2+ exchange was unsuccessful, it was decided to 
investigate the effect of pH on the stability of the Zn2+ -bound form of the protein. At 
high pH Zn2+ ions are tightly bound whereas below pH 5.5 Zn2+coordination is expected 
to break down due to the sulphur atoms, which undergo oxidation due to DTT as a 
reducing agent (Davies et al., 2005). 1 D spectra of RING_sl were recorded in different 
pH buffers ranging from pH 6.0 to 5.2 as described in Section 2.7.4. As pH decreases 
steady loss of structure can be seen, in particular by a reduction in the size of amide 
resonance to the left of the 9 ppm and the methyl resonance at 0.1 ppm. At pH 5.2 the 
protein is almost completely unfolded. We concluded from our results that binding of 
Zn2+ was likely to be required for folding of the protein (see Fig 4.5). 
 
4.3.2 Perturbation of 15N-HSQC spectra 
To confirm results obtained from pH investigation, that then folded protein bound Zn2+ 
ions, a second exchange experiment of Zn2+ by Cd2+, was done again at pH 6.0. This time 
the results were conclusive. 25 μl of 50 mM 113Cd-EDTA was added to a 2.805 mM 15N-
labelled RING_sl sample to a final concentration of 2 mM. Over a 2-week period a 
number of peaks disappeared and new peaks appeared. Fig 4.6 shows overlay spectra 
before (black) and after the exchange had taken place. Some peaks decayed/grew at a 
faster rate than others, suggesting that there are two binding sites with different affinities 
for Zn2+ and Cd2+ ions. 
 
4.3.3 Refolding induced by Zn2+ and Cd2+  
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After few weeks from the exchange experiment it was clear from the 15N-HSQC spectra 
that both the Zn2+ and Cd 2+ bound RING_sl samples stored at 4 oC that they contained 
some unfolded protein. In an attempt to separate the unfolded protein from the folded 
protein, as well as to investigate whether the Cd2+ -bound form would remain folded after 
the removal of excess 113Cd-EDTA, both samples were subjected to size exclusion 
chromatography. NMR buffer was used without addition of either Zn2+ or Cd2+. Fig 4.7 
shows the appearance of a peak at the position expected for the bound protein (peak 2) 
and another broad peak (peak 1) suggesting that peak 1 and peak 2 correspond to the 
unfolded and folded protein respectively.  
Fractions collected from both peaks were analysed by SDS PAGE gels, which confirmed 
that both peaks correspond to RING_sl protein. Fractions pooled from the narrow (peak 
2) and the broad (peak 1) were analysed by NMR, the 15N-HSQC spectrum shown in Fig 
4.8 confirmed that they correspond to the folded and unfolded protein respectively. 
Similar results were obtained for Zn-bound form of RING_sl. After the addition of 
CdCl2/ZnCl2 to the unfolded protein (Fig 4.8B/E) the protein refolded (Fig 4.8C&F) as 
indicated by the appearance of more amide protons that are well dispersed on both 
dimensions. These investigations also reveal that RING_sl has strong affinity for Cd2+ 
/Zn2+. 
 
 
 
4.3.4 Direct detected 113Cd NMR experiments 
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Since the coherence transfer between Cd2+ and RING_sl protons observed was not such 
as observed for CNOT4 and p44 (see Section 1.7), therefore Cd2+ -bound to the protein 
was observed using directly detected 1D 113Cd spectrum. The 1D spectrum in Fig 4.9A 
contains three peaks: the peak at 556.6 ppm corresponds to the published chemical shift 
of 113Cd-EDTA (Harris and Mann, 1978), where the spectrum is referenced to Di-methyl 
Cd2+   (113CdMe) is at 0 ppm. When the spectrum is referenced to CdSO4 is at 0 ppm, the 
two peaks on the left hand side of the spectrum correspond to chemical shifts in the 
vicinity of 720 ppm, which is consistent with the results obtained for CNOT4 and p44.  
 
It was concluded that these two peaks correspond to the Cd2+ ions in the two sites of the 
protein. A series of 1D’s recorded during the 2 week period of the exchange to occur 
(data not shown), showed build up of two peaks and decrease of 113Cd-EDTA peak, 
confirming that the peaks correspond to Cd2+ ions bound to the protein. Two peaks 
correspond to Cd2+ exchanging into two sites in protein. 
 
4.3.5 113Cd-1H coherence transfer experiments 
The 1D directly detected spectrum shown in Fig 4.9A, indicated the frequency of the 
required carrier and the spectral width, to be able to locate the exchange on the 113Cd-1H-
HSQC spectrum. Using the new values, we were able to observe the coherence transfer 
from Cd2+ to protons in the protein.  
 
The peaks at the top edge of the spectrum (Fig 4.9B) correspond to coherence transfer 
between 113Cd2+ and the protons of EDTA. The same spectrum is shown in Fig 4.10, 
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which is the zoomed area of the two lines of peaks at around 720 ppm corresponding to 
coherence transfer between 113Cd2+ and the Hβ protons in the coordinating cysteine 
residues in RING_sl. As expected the proton chemical shifts are in the region 3 ppm, 
which is characterisc of cysteine Hβ protons (http://www.bmrb.wisc.edu/ref_info/statel.ht
ml). Note that the projection of the 113Cd2+ -1H-HSQC only the vertical axis gives the 
same spectrum as the 1D in (Fig 4.9A). Assignment of the side chains in the protein will 
allow us to determine which cysteine residues are bound to each Cd2+. 
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Chapter 5: Discussion and conclusion  
 
Sequence analysis of the RBBP6 RING finger domain indicated that the protein contains 
conserved cysteine residues, suggesting that like other RING finger domains is possible 
that the RBBP6 RING finger might coordinate Zn2+ ions. It also pointed to the possibility 
that RBBP6 RING finger can also be classified as a member of the U box family, which 
do not require Zn2+ in order to fold, although they adopt the same structure as RING 
fingers. As shown the full RBBP6 RING finger construct domain contained an 
unstructured region at its N-terminus, and not suitable for further investigation of the 
domain using NMR. The aims for the study were therefore to truncate the N-terminal 
region and produce two constructs RING_sl and RING_ss, being shortened by 19 and 13 
amino acid residues respectively, and to investigate the Zn2+ binding properties of the 
domain using NMR spectroscopy.   
 
Both shortened constructs were successfully amplified, cloned and soluble protein 
expressed at high levels in rich media. However in minimal media soluble expression was 
only achieved following addition of 100 μM ZnSO4, which suggest that Zn2+ is required 
in order for the protein to fold. Purification was achieved by a combination of affinity, 
ion exchange and size exclusion chromatography. Protein samples suitable for NMR 
experiments were obtained at 0.5 mM concentration. 
 
Using both 1D proton and 15N-HSQC spectra, RING_sl and RING_ss were found to be 
folded and unfolded respectively. We concluded from this that the boundary of the 
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domain falls between the two shortened constructs. The quality of the 15N-HSQC 
spectrum of RING_sl was significantly better than the 15N-HSQC spectrum of the 
previous construct, which will facilitate future structural work on the RBBP6 RING 
finger domain. 
 
Using 1D proton spectra we showed that RING_sl unfolds rapidly as a function of pH as 
the pH drops below 6.0, which we interpreted as loosening of the coordination bonds. 
The addition of Cd2+ and Zn2+ to unfolded samples refolded the protein, confirming that 
Zn2+ is required for folding. Addition of 113Cd-EDTA to the protein produced small 
chemical shift changes in the 15N-HSQC spectrum, indicating that Cd2+ ions are able to 
replace Zn2+ ions without significantly changing the conformation of the protein. The 
changes took place over a time period of approximately 1 week for some residues, 
whereas other residues took almost 2 weeks to exchange fully, indicating that two 
different coordination sites may be involved. As observed the exchange was not the same 
for the two sites indicating the differences in affinity. 
 
Using directly detected 113Cd spectra we showed that Cd2+ binds to two different sites in 
the domain. This method, which has not been used previously to study metal binding in 
proteins, is easier and faster than recording 113Cd indirectly detected experiments such as 
the 113Cd-1H-HSQC. Using a 113Cd-1H-HSQC experiment we were able to observe 
transfer of coherence between the Cd2+ and the Hβ protons of the coordinating cysteines. 
The fact that the chemical shifts of the two Cd2+ ions are closer together than those 
observed for two other C4C4 RING fingers suggest that the chemical character of the two 
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coordination sites is even more similar than in those cases. Hence we conclude that the 
RBBP6 is more likely to be a C4C4 RING finger than a C3NC4 RING. However the 
question will remain unanswered until the structure of the domain has been determined at 
high resolution.   
 
Assignments of the side chain chemical shifts of the RING finger is beyond the scope of 
this thesis, and so we were not able to determine the precise identities of the coordinating 
amino acid residues. However from the chemical shifts of the coordinating protons we 
can conclude that the majority of the coordinating residues are cysteines.  
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Appendix I: Amino acid sequence of the previous RBBP6 RING and shorted 
constructs. 
 
 
Original RING construct 
 
 
GPLGSEEPSSSSEEDDPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTAL 
LESDEHTCPTCHQNDVSPDALIANKFLRQAVNNFKNETGYTKRLRKQ 
 
RING_sl 
GPLGSEDDPIPDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQN
DVSPDALIANKFLRQAVNNFKNETGYTKRLRKQ 
 
RING_ss 
GPLGSDELLCLICKDIMTDAVVIPCCGNSYCDECIRTALLESDEHTCPTCHQNDVSPDA
LIANKFLRQAVNNFKNETGYTKRLRKQ 
 
The original RING construct was shortened by 13 amino acid residue (red arrow), and by 
19 amino acids (blue arrow) to produce RING_sl and RING_ss constructs respectively. 
The first 5 amino acids are artifacts produced by the pGEX-6P-2 expression system.  
 
 
 
 
 
APPENDIX II: Sequence analysis of RING_sl cloned into pGEM-T Easy (sequenced 
by INQABA laboratory) 
 
Forward RING_sl 1B T7 
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Alignment of RING finger short_long (Insilco) and sequenced RING finger 
short_long domain 
Query-Insilico sequence, and Sbjct-Sequenced sequence  
Score =  531 bits (276),  Expect = 5e-148 
Identities = 278/279 (99%), Gaps = 0/279 (0%) 
Strand=Plus/Plus 
 
Query  7    GGATCCGAAGATGATCCTATCCCAGATGAATTGTTGTGTCTCATCTGCAAGGATATTATG  66 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  57   GGATCCGAAGATGATCCTATCCCAGATGAATTGTTGTGTCTCATCTGCAAGGATATTATG  116 
 
Query  67   ACTGATGCTGTTGTGATTCCCTGCTGTGGAAACAGTTACTGTGATGAATGTATAAGAACA  126 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  117  ACTGATGCTGTTGTGATTCCCTGCTGTGGAAACAGTTACTGTGATGAATGTATAAGAACA  176 
 
Query  127  GCACTCCTGGAATCAGATGAGCACACATGTCCGACGTGTCATCAAAATGATGTTTCTCCT  186 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  177  GCACTCCTGGAATCAGATGAGCACACATGTCCGACGTGTCATCAAAATGATGTTTCTCCT  236 
 
Query  187  GATGCTTTAATTGCCAATAAATTTTTACGACAGGCTGTAAATAACTTCAAAAATGAAACT  246 
            |||||||||||||||||||||||||||||||| ||||||||||||||||||||||||||| 
Sbjct  237  GATGCTTTAATTGCCAATAAATTTTTACGACAAGCTGTAAATAACTTCAAAAATGAAACT  296 
 
Query  247  GGCTATACAAAAAGACTACGAAAACAGTGATAACTCGAG  285 
            ||||||||||||||||||||||||||||||||||||||| 
Sbjct  297  GGCTATACAAAAAGACTACGAAAACAGTGATAACTCGAG  335 
 
 
 
 
Reverse RING finger short_long 1B M13R  
 
Query-Insilico sequence, and Sbjct-Sequenced sequence  
Alignment of RING finger short_long (Insilco) and sequenced RING finger short_long,  
Score =  529 bits (275),  
Identities = 284/286 (99%), Gaps = 1/286 (0%) 
  
Query  1    GAGGCGGGATCCGAAGATGATCCTATCCCAGATGAATTGTTGTGTCTCATCTGCAAGGAT  60 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  415  GAGGCGGGATCCGAAGATGATCCTATCCCAGATGAATTGTTGTGTCTCATCTGCAAGGAT  356 
 
Query  61   ATTATGACTGATGCTGTTGTGATTCCCTGCTGTGGAAACAGTTACTGTGATGAATGTATA  120 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  355  ATTATGACTGATGCTGTTGTGATTCCCTGCTGTGGAAACAGTTACTGTGATGAATGTATA  296 
 
Query  121  AGAACAGCACTCCTGGAATCAGATGAGCACACATGTCCGACGTGTCATCAAAATGATGTT  180 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  295  AGAACAGCACTCCTGGAATCAGATGAGCACACATGTCCGACGTGTCATCAAAATGATGTT  236 
 
Query  181  TCTCCTGATGCTTTAATTGCCAATAAATTTTTACGACAGGCTGTAAATAACTTCA-AAAA  239 
            |||||||||||||||||||||||||||||||||||||| |||||||||||||||| |||| 
Sbjct  235  TCTCCTGATGCTTTAATTGCCAATAAATTTTTACGACAAGCTGTAAATAACTTCAAAAAA  176 
 
Query  240  TGAAACTGGCTATACAAAAAGACTACGAAAACAGTGATAACTCGAG  285 
            |||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  175  TGAAACTGGCTATACAAAAAGACTACGAAAACAGTGATAACTCGAG  130 
Translation of experimental RING_sl sequence 
ATA TGG CAG CTC GCA TGC TCC GGC GCC ATG CCG GCC GCC GGA ATT CGA TTG AGC GGA TCC 
 I   W   Q   L   A   C   S   G   A   M   P   A   A   G   I   R   L   S   G   S   
GAA GAT GAT CCT ATC CCA GAT GAA TTG TTG TGT CTC ATC TGC AAG GAT ATT ATG ACT GAT 
 E   D   D   P   I   P   D   E   L   L   C   L   I   C   K   D   I   M   T   D  
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GCT GTT GTG ATT CCC TGC TGT GGA AAC AGT TAC TGT GAT GAA TGT ATA AGA ACA GCA CTC 
 A   V   V   I   P   C   C   G   N   S   Y   C   D   E   C   I   R   T   A   L  
CTG GAA TCA GAT GAG CAC ACA TGT CCG ACG TGT CAT CAA AAT GAT GTT TCT CCT GAT GCT 
 L   E   S   D   E   H   T   C   P   T   C   H   Q   N   D   V   S   P   D   A  
TTA ATT GCC AAT AAA TTT TTA CGA CAA GCT GTA AAT AAC TTC AAA AAT GAA ACT GGC TAT 
 L   I   A   N   K   F   L   R   Q   A   V   N   N   F   K   N    E   T   G   Y  
ACA AAA AGA CTA CGA AAA CAG TGA TAA CTC GAG CGC CTC AAT CAC TAG TGA ATT CGC GGC 
 T    K   R   L   R   K   Q  *   -  L   E   R   L   N   H   *    -   I   R   G  
CGC CTG CAG GTC GAC CAT ATG GGA GAG CTC CCA ACG CGT TGG ATG CAT AGC TTG AGT ATT 
 R   L   Q   V   D   H   M   G   E   L   P   T   R   W   M   H   S   L   S   I  
CAA- mutation CAG replaced by CAA, but still code for the same amino acid glutamine 
 
Translation of expected RING_sl sequence 
 
gag gcg gga tcc gaa gat gat cct atc cca gat gaa ttg ttg tgt ctc atc tgc aag gat 
 E   A   G   S   E   D   D   P   I   P   D   E   L   L   C   L   I   C   K   D  
att atg act gat gct gtt gtg att ccc tgc tgt gga aac agt tac tgt gat gaa tgt ata 
 I   M   T   D   A   V   V   I   P   C   C   G   N   S   Y   C   D   E   C   I  
aga aca gca ctc ctg gaa tca gat gag cac aca tgt ccg acg tgt cat caa aat gat gtt 
 R   T   A   L   L   E   S   D   E   H   T   C   P   T   C   H   Q   N   D   V  
tct cct gat gct tta att gcc aat aaa ttt tta cga cag gct gta aat aac ttc aaa aat 
 S   P   D   A   L   I   A   N   K   F   L   R   Q   A   V   N   N   F   K   N  
gaa act ggc tat aca aaa aga cta cga aaa cag tga taa ctc gag gcg gag 
 E   T   G   Y   T   K   R   L   R   K   Q   *   *   L   E   A   E   
 
Restriction sites are highlighted in red, CTCGAG- Xho I and GGATCC- Bam HI. 
“Query” denotes the expected sequence, and “Sbjct” denotes the experimental sequence 
determined by sequencing sequence. A single silent mutation appears at position 219 of 
the Query sequence.  
  
Appendix III: Sequence analysis of RING_ss cloned into pGEX-6P2 expression 
vector (sequenced by INQABA laboratory) 
 
Forward RING_ss 1B M13R  
 
Alignment of RING finger SS (Insilco) and sequenced RING finger SS,  
Query-Insilico sequence, sbjct: sequenced sequence. 
Score =  498 bits (259), Identities = 259/259 (100%), Gaps = 0/259 (0%) 
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Query  9    ATCCGATGAATTGTTGTGTCTCATCTGCAAGGATATTATGACTGATGCTGTTGTGATTCC  68 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  49   ATCCGATGAATTGTTGTGTCTCATCTGCAAGGATATTATGACTGATGCTGTTGTGATTCC  108 
 
Query  69   CTGCTGTGGAAACAGTTACTGTGATGAATGTATAAGAACAGCACTCCTGGAATCAGATGA  128 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  109  CTGCTGTGGAAACAGTTACTGTGATGAATGTATAAGAACAGCACTCCTGGAATCAGATGA  168 
 
Query  129  GCACACATGTCCGACGTGTCATCAAAATGATGTTTCTCCTGATGCTTTAATTGCCAATAA  188 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  169  GCACACATGTCCGACGTGTCATCAAAATGATGTTTCTCCTGATGCTTTAATTGCCAATAA  228 
 
Query  189  ATTTTTACGACAGGCTGTAAATAACTTCAAAAATGAAACTGGCTATACAAAAAGACTACG  248 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  229  ATTTTTACGACAGGCTGTAAATAACTTCAAAAATGAAACTGGCTATACAAAAAGACTACG  288 
 
Query  249  AAAACAGTGATAACTCGAG  267 
            ||||||||||||||||||| 
Sbjct  289  AAAACAGTGATAACTCGAG  307 
 
 
 
 
Reverse RING_ss 1B M13R  
 
Alignment of RING finger SS (Insilco) and sequenced RING finger SS, 
Query-Insilico sequence, sbjct: sequenced sequence.  
Score =  504 bits (262), Identities = 262/262 (100%), Gaps = 0/262 (0%) 
 
Query  6    GGGATCCGATGAATTGTTGTGTCTCATCTGCAAGGATATTATGACTGATGCTGTTGTGAT  65 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  311  GGGATCCGATGAATTGTTGTGTCTCATCTGCAAGGATATTATGACTGATGCTGTTGTGAT  252 
 
Query  66   TCCCTGCTGTGGAAACAGTTACTGTGATGAATGTATAAGAACAGCACTCCTGGAATCAGA  125 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  251  TCCCTGCTGTGGAAACAGTTACTGTGATGAATGTATAAGAACAGCACTCCTGGAATCAGA  192 
 
Query  126  TGAGCACACATGTCCGACGTGTCATCAAAATGATGTTTCTCCTGATGCTTTAATTGCCAA  185 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  191  TGAGCACACATGTCCGACGTGTCATCAAAATGATGTTTCTCCTGATGCTTTAATTGCCAA  132 
 
Query  186  TAAATTTTTACGACAGGCTGTAAATAACTTCAAAAATGAAACTGGCTATACAAAAAGACT  245 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  131  TAAATTTTTACGACAGGCTGTAAATAACTTCAAAAATGAAACTGGCTATACAAAAAGACT  72 
 
Query  246  ACGAAAACAGTGATAACTCGAG  267 
            |||||||||||||||||||||| 
Sbjct  71   ACGAAAACAGTGATAACTCGAG  50 
 
 
 
 
 
 
 
Translation of experimental RING_ss sequence  
 
 
gga gcg agg aca aca caa cac att gca tcg atg ccc cgc ctc tcg ttt caa acg tcg ccg gtg ggc  
 G   A   R   T   T   Q   H   I   A   S   M   P   R   L   S   F   Q   T   S   P   V   G 
ttt gag ggg ggt ggc ggg ggg cgc gtg ggc tgg caa gcc acg ttt ggt ggt ggc Gac cat cct cca 
 F   E   G   G   G   G   G   R   V   G   W   Q   A   T   F   G   G   G   D   H   P   P 
aaa tcg gat ctg gaa gtt ctg ttc cag ggg ccc ctg gga tcc gat gaa ttg ttg tgt ctc atc tgc 
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 K   S   D   L   E   V   L   F   Q   G   P   L   G   S   D   E   L   L   C   L   I   C 
aag gat att atg act gat gct gtt gtg att ccc tgc tgt gga aac agt tac tgt gat gaa tgt ata 
 K   D   I   M   T   D   A   V   V   I   P   C   C   G   N   S   Y   C   D   E   C   I 
aga aca gca ctc ctg gaa tca gat gag cac aca tgt ccg acg tgt cat caa aat gat gtt tct cct 
 R   T   A   L   L   E   S   D   E   H   T   C   P   T   C   H   Q   N   D   V   S   P 
gat gct tta att gcc aat aaa ttt tta cga cag gct gta aat aac ttc aaa aat gaa act ggc tat 
 D   A   L   I   A   N   K   F   L   R   Q   A   V   N   N   F   K   N   E   T   G   Y 
aca aaa aga cta cga aaa cag tga taa ctc gag cgg ccg cat cgt gac tga ctg acg atc tgc ttc 
 T   K   R   L   R   K   Q   -   -   L   E   R   P   H   R   D   -   L   T   I   C   F 
gcg cgt ttc ggt gatg 
 A   R   F   G   D 
 
 
Translation of expected RING_ss sequence 
 
gag gcg gga tcc gat gaa ttg ttg tgt ctc atc tgc aag gat att atg act gat gct gtt gtg att  
 E   A   G   S   D   E   L   L   C   L   I   C   K   D   I   M   T   D   A   V   V   I 
ccc tgc tgt gga aac agt tac tgt gat gaa tgt ata aga aca gca ctc ctg gaa tca gat gag cac 
 P   C   C   G   N   S   Y   C   D   E   C   I   R   T   A   L   L   E   S   D   E   H 
aca tgt ccg acg tgt cat caa aat gat gtt tct cct gat gct tta att gcc aat aaa ttt tta cga 
 T   C   P   T   C   H   Q   N   D   V   S   P   D   A   L   I   A   N   K   F   L   R 
cag gct gta aat aac ttc aaa aat gaa act ggc tat aca aaa aga cta cga aaa cag tga taa ctc 
 Q   A   V   N   N   F   K   N   E   T   G   Y   T   K   R   L   R   K   Q   *   *   L 
gag gcg gag 
 E   A   E   
“Query” denotes the expected sequence, and “Sbjct” denotes the experimental sequence 
determined by sequencing sequence. The experimental and expected sequences are in 
100% agreement.  
 
 
Appendix IV: Prediction of protein parameters 
 
A.Parameters for RING_sl 
ProtParam 
User-provided sequence: 
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               10               20                 30                 40               
50                   60  
GPLGSEDDPI PDELLCLICK DIMTDAVVIP CCGNSYCDEC IRTALLESDE HTCPTCHQND  
 
               70                 80                 90  
VSPDALIANK FLRQAVNNFK NETGYTKRLR KQ  
 
Please note the modified algorithm for extinction coefficient. 
 
 
Number of amino acids: 92 
 
Molecular weight: 10229.6 
 
Theoretical pI: 4.67 
 
Amino acid composition:  
Ala (A) 5 5.4% Arg (R) 4 4.3% Asn (N) 6 6.5% Asp (D) 9 9.8% Cys (C) 8 
8.7% Gln (Q) 3 3.3% Glu (E) 6 6.5% Gly (G) 4 4.3% His (H) 2 2.2% Ile (I) 
6 6.5% Leu (L) 9 9.8% Lys (K) 5 5.4% Met (M) 1 1.1% Phe (F) 2 2.2% Pro 
(P) 6 6.5% Ser (S) 4 4.3% Thr (T) 6 6.5% Trp (W) 0 0.0% Tyr (Y) 2 2.2% 
Val (V) 4 4.3% Asx (B) 0 0.0% Glx (Z) 0 0.0% Xaa (X) 0 0.0% 
 
Total number of negatively charged residues (Asp + Glu): 15 
Total number of positively charged residues (Arg + Lys): 9 
 
Atomic composition: 
 
Carbon      C        435 
Hydrogen  H        698 
Nitrogen    N        122 
Oxygen     O        144 
Sulfur        S          9 
 
Formula: C435H698N122O144S9 
Total number of atoms: 1408 
 
Extinction coefficients: 
 
This protein does not contain any Trp residues. Experience shows that 
this could result in more than 10% error in the computed extinction 
coefficient. 
 
Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in 
water. 
Ext. coefficient     3480 
Abs 0.1% (=1 g/l) 0.340, assuming ALL Cys residues appear as half 
cystines 
 
Ext. coefficient     2980 
Abs 0.1% (=1 g/l) 0.291, assuming NO Cys residues appear as half 
cystines 
 
 
Estimated half-life: 
 
The N-terminal of the sequence considered is G (Gly). 
 
The estimated half-life is: 30 hours (mammalian reticulocytes, in 
vitro). 
                            >20 hours (yeast, in vivo). 
                            >10 hours (Escherichia coli, in vivo). 
 
Instability index: 
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The instability index (II) is computed to be 38.52 
This classifies the protein as stable. 
 
 
Aliphatic index: 81.63 
 
Grand average of hydropathicity (GRAVY): -0.376 
 
 
 
B.Parameters for RING_ss 
 
ProtParam 
User-provided sequence: 
 
               10                20                30                40                
50                  60  
GPLGSDELLC LICKDIMTDA VVIPCCGNSY CDECIRTALL ESDEHTCPTC HQNDVSPDAL  
 
               70                  80  
IANKFLRQAV NNFKNETGYT KRLRKQ  
 
Please note the modified algorithm for extinction coefficient. 
 
 
Number of amino acids: 86 
 
Molecular weight: 9562.9 
 
Theoretical pI: 5.18 
 
Amino acid composition:  
Ala (A) 5 5.8% Arg (R) 4 4.7% Asn (N) 6 7.0% Asp (D) 7 8.1% Cys (C) 8 
9.3% Gln (Q) 3 3.5% Glu (E) 5 5.8% Gly (G) 4 4.7% His (H) 2 2.3% Ile (I) 
5 5.8% Leu (L) 9 10.5% Lys (K) 5 5.8% Met (M) 1 1.2% Phe (F) 2 2.3% Pro 
(P) 4 4.7% Ser (S) 4 4.7% Thr (T) 6 7.0% Trp (W) 0 0.0% Tyr (Y) 2 2.3% 
Val (V) 4 4.7% Asx (B) 0 0.0% Glx (Z) 0 0.0% Xaa (X) 0 0.0% 
 
Total number of negatively charged residues (Asp + Glu): 12 
Total number of positively charged residues (Arg + Lys): 9 
 
Atomic composition: 
Carbon      C        406 
Hydrogen   H        656 
Nitrogen    N        116 
Oxygen      O        132 
Sulfur         S          9 
 
Formula: C406H656N116O132S9 
Total number of atoms: 1319 
 
Extinction coefficients: 
 
This protein does not contain any Trp residues. Experience shows that 
this could result in more than 10% error in the computed extinction 
coefficient. 
 
Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in 
water. 
 
Ext. coefficient     3480 
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Abs 0.1% (=1 g/l) 0.364, assuming ALL Cys residues appear as half 
cystines 
 
Ext. coefficient     2980 
Abs 0.1% (=1 g/l) 0.312, assuming NO Cys residues appear as half 
cystines 
 
 
Estimated half-life: 
 
The N-terminal of the sequence considered is G (Gly). 
The estimated half-life is: 30 hours (mammalian reticulocytes, in 
vitro). 
                            >20 hours (yeast, in vivo). 
                            >10 hours (Escherichia coli, in vivo). 
 
 
Instability index: 
 
The instability index (II) is computed to be 37.25 
This classifies the protein as stable. 
 
 
Aliphatic index: 82.79 
 
Grand average of hydropathicity (GRAVY): -0.295 
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Figure 1.1 Schematic representations of the domain structure of RBBP6 homologues from different 
species. The RBBP6 protein consists of an N-terminal domain (DWNN), a zinc finger, and a RING finger 
domain, which are present as a single copy transcript in all complete eukaryotic genomes analysed to date 
including the parasite single celled Encephalitozoon cuniculi. In vertebrates and insects, the RBBP6 
includes a long C-terminal extension, which includes an Rb-binding domain, a p53-binding domain, an SR 
domain and a nuclear localisation domain. Vertebrates also contain a short form, which consists of the N-
terminal (DWNN) domain (figure adapted from Pugh et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
Figure 1.2 Alignment of RBBP6 RING finger against a number of RING finger and RING finger-like 
proteins. Cysteine and histidine residues coordinating Zn2+ are indicated in rectangles. The two sites 
coordinating Zn2+ are indicated by arrows Included are: C3HC4 RING fingers MAT1 (1g25, res 1-65 ), 
RAG1 (1rmd, res 1-61), c-Cbl (1fbv, res 1-154), IEEHV (1chc,1-68), and BRCA1 (1jm7a, 1-112); C4C4 
RING fingers CNOT4 (1e4u, res 1-78) and p44 (1z60, res 1-59 ); C3HHC3 (RING-H2) EL5 (1iym, res 1-
55); C4HC3 PHD finger (1xwh, res 1-66), C2H2C4 Hdm2 (2hdpA, res 1-63); U box (1n87, RES 1-56). In 
the U box domain, cysteine or histidine zinc binding residues are replaced by other residues. As can be seen 
from the alignment, RBBP6 RING is either a C4C4 RING finger or a novel 
C3NC4 RING finger.  (Alignment created using Clustal X and edited using Seaview, sequences are 
referenced by their PDB accession numbers). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
Figure 1.3 Schematic representation of the zinc coordination in RING finger and PHD domains. Zn I 
is coordinated by cysteine or histidine residues 1, 2, 5 and 6, and Zn II by residues 4, 3, 7 and 8, forming a 
cross-braced pattern. Cysteine residues are shown in circles and the histidine residues are shown in squares. 
The PHD and RING fingers have identical topology but differ in the arrangement of the secondary 
structure, with the α-helix forming part of the first zinc coordination site in the RING and the second 
coordination site in the PHD (figure adapted from Bottomley et al., 2005).  
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Figure 1.4 3D Structure of the MAT1 C3HC4 RING finger. The structure is stabilised by two zinc ions 
(indicated by magenta spheres). The secondary structure consists of a three-stranded anti-parallel β-sheet 
(shown in red, yellow and orange) and a single α-helix (blue), linked by loops (grey) (figure adapted from 
Kellenberger et al., 2005) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Cartoon representation of a 3D structure of the PHD from the AIRE1 (PDB: 1XWH). Zn I 
is coordinated by Cys299, Cys302, His319 and Cys322 and Zn II by Cys311, Cys314, Cys337 and Cys340, 
in a cross-braced manner. Zn is shown in grey spheres, β strands are shown in yellow, the α helix is shown 
in red (figure created using Pymol). 
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Figure 1.6 The ubiquitin-proteasome pathway. Ubiquitination proceeds in three steps: E1 first activates 
ubiquitin and then transfer it to E2. In the final step ubiquitin is either conjugated directly to the substrate 
from E2 (indicated with a circle) or a thiol ester bond is formed between the E2 and E3 enzymes before 
ubiquitin can be conjugated to the substrate (indicated with a square) depending on the class of E3 ubiquitin 
ligase catalysing the reaction. After formation of the polyubiquitin chain the target protein is degraded in 
the 26S proteasome and ubiquitin is recycled (figure adapted from Zolk et al., 2006).   
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 1.7 Tetrahedral coordination found in RING finger proteins. Section taken from site 2 of C4C4 
CNOT4 RING finger (PDB:1e4u). Zn II is coordinated by four cysteine residues through the sulphur 
atoms. The atoms are coloured as follows, carbons (green), oxygen (red), hydrogen (grey), nitrogen (blue) 
and sulphur (orange). (figure created using Pymol). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.8 RING-H2 domain from EL5 requires Zn2+ in order to fold. The domain structure of EL5 (a), 
including the RING-H2 domain (residues 129-181). The domain is folded in the presence of zinc (b), but 
the addition of EDTA to chelate Zn2+ unfolds the protein (d). The addition of excess Zn2+ refolds the 
protein (c), indicating that the protein requires Zn2+ in order to fold (figure adapted from Katoh et al., 
2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                              
 
 
 
 
Figure 1.9 RING2 from HHARI requires Zn2+ in order to fold.  (a) HHARI contains two RING finger 
domains (RING1 and RING 2) separated by an “In Between RING” domain (IBR). When expressed in the 
presence of zinc RING2 is folded (b), whereas when expressed in the absence of zinc it is unfolded (c) 
(15N-HSQC spectra adapted from Capili et al., 2004). 
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Figure 1.10 Coordination of Zn2+ by cysteine residues. The Hβ protons are separated from the metal ion 
by three covalent bonds and the coordination bond. (Picture created using Pymol) 
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Figure 1.11 Determination of zinc coordinating residues by replacement of zinc with 113Cd in the p44 
RING domain. (A) Chemical shifts differences of the amide protons and nitrogen’s of the p44 C4C4 
RING domain following exchange of Zn2+ by Cd2+showing (B), 113Cd-HSQC spectrum, showing that Zn I 
and Zn II are coordinated in a cross-brace manner by Cys (348, 368, 371 and 345) and Cys (363, 360, 382, 
and 385) respectively (figure adapted from Kellenberger et al., 2005). 
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Figure 1.12 Determination of zinc coordinating residues by replacement of zinc with 113Cd in the 
CNOT4 RING domain. Chemical shift differences of the amide protons and nitrogen’s between native 
Zn-bound CNOT4 and the Cd-bound CNOT4 are shown in (A). 113Cd-1H HSQC spectrum (B) shows the 
correlation between 113Cd and Hβ protons of the cysteine residues. Site 1 contains residues Cys 14, 17,38, 
and 41 and site 2 contains residues Cys33, 53, and 56. Hβ protons for cysteine residues have chemical shifts 
in the vicinity of  2.5-4.0 ppm (figure adapted from Hanzawa et al., 2001). 
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Figure 1.13 Zn2+or Cd2+ binding in oxidised Cytochrome c. 15N-HSQC of Cytochrome c, before (red) 
and after (black) the addition of Zn2+. Chemical shift changes were observed for E104, N103, T102, H33 
and K99. The shifts are only observed for a small number of residues meaning that binding of Zn2+ has no 
effect on the integrity of the whole protein (figure adapted from Gourion-Arsiquaud et al., 2005). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      
              5’gaggcgggatccgaagatgatcctatcccagat3’ Forward primer 1 
                  5’gaggcgggatccgatgaattgttgtgtctcatctg3’ Forward primer 2 
 
5’gaggagccatcttcttcctcagaagaagatgatcctatcccagatgaattgttgtgtctcatctgcaaggatattatgactgatgctgttgtgattccctgctgtggaaacagttactg 
 
E  E  P  S  S  S  S  E  E  D  D  P  I  P  D  E  L  L  C  L  I  C  K  D  I  M  T  D  A  V  V  I  P  C  C  G  N  S  Y 
 
  tgatgaatgtataagaacagcactcctggaatcagatgagcacacatgtccgacgtgtcatcaaaatgatgtttctcctgatgctttaattgccaataaatttttacgacaggctgtaa 
 
  C D  E  C  I  R  T  A  L  L  E  S  D  E  H  T  C  P  T  C  H  Q  N  D  V  S  P  D  A  L  I  A  N  K  F  L  R  Q  A  V 
 
     ataacttcaaaaatgaaactggctatacaaaaagactacgaaaacag 3’ 
      N  N  F  K  N  E  T  G  Y  T  K  R  L  R  K Q 
 
                                            
 
                         3’tatgtttttctgatgcttttgtcactattgagctcgcggag 5’ Reverse primer 
 
 
Figure 3.1 Primers used for PCR amplification of RING finger. The sequence is taken from the human 
RBBP6 (Accession number NP_008841 (protein sequence); NM_006910 (nucleotide sequence), residues 
249-335. Bam HI and Xho I restriction endonucleases sites are highlighted in pink. Stop codons are 
highlighted in bold. Forward primer 1 and 2 will shorten the RING finger by 13 and 19 amino acid residues 
respectively. 
 
 
 
 
 
 
 
 
 
 
QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
 
Figure 3.2 1% agarose gel electrophoresis showing PCR amplification of both shortened RING 
constructs. Lanes 2 and 3 correspond to RING_ss and RING_sl respectively. Lane 1 corresponds to the 
negative control (no DNA template) and lane M corresponds to a Mass ruler DNA ladder marker. RING_ss 
was shortened by 57 base pairs (19 amino acids) giving a size of 243 bp, and RING_sl was shortened by 39 
base pairs (13 amino acids) giving a size of 261 bp. 
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Figure 3.3 1% agarose gel electrophoresis showing colony PCR screening for recombinant clones. 
Lanes 3-7 correspond to RING_sl, lanes 8-11correspond to RING_ss. The expected sizes for positive 
clones are 461 and 443 respectively. Positive clones for RING_sl are in lanes 3,4,6; lane 8 contains a single 
positive RING_ss clone. Negative clones are in lanes 5,7, 9-11. Lane 1 is the negative control (no DNA 
template), lane 2 contains a positive control for the PCR reaction for which the template was pGEM-
DWNN from (Encephalitozoon cuniculi), lane M corresponds to pTZ marker.  
 
 
QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
 
Figure 3.4 1% agarose gel electrophoresis showing restriction digestion of pGEM-T Easy-RING 
shortened constructs with Bam HI and Xho I. Lanes 1 & 2 correspond to undigested and digested 
pGEM-T Easy RING_ss respectively. Lanes 3 & 4 correspond to undigested and digested pGEM-T Easy-
RING_sl respectively. Lane M corresponds to the Mass ruler DNA ladder marker. The expected size for 
the released insert in lane 4 is 261 bp. 
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QuickTime™ and a
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Figure 3.5 1% agarose gel electrophoresis showing restriction digestion of pGEX-6P-2-RING_sl 
constructs with Bam HI and Xho I. Lane 1 corresponds to undigested plasmid, lanes 2-9 correspond to 
digested plasmid. Positive clones and negative clones are in lanes 2-4 & 6 and lanes 5, 7-9 respectively. 
Lane M (left) corresponds to Mass ruler DNA ladder marker and lane M (right) corresponds to pTZ 
marker. 
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Figure 3.6 Coomasie Blue stained proteins separated by a 16% SDS PAGE gel electrophoresis 
showing small-scale screen for GST-RING_sl expression. Lanes 1, 3, 5 & 7 correspond to induced 
expression and lanes 2, 4, 6 & 8 corresponds to uninduced expression. Lane 9 contains GST, and lane M 
contains a protein molecular weight marker. Induced expression is characterised by a prominent band at 
~36.8 kD, which is not present in the uninduced lanes.  
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Figure 3.7 Large-scale expression and affinity purification of GST-RING_sl and its separation from 
GST by 3C protease. In (A) RING_sl was expressed in minimal media in the presence of 100 μM ZnSO4. 
Lane 1 corresponds to the lysate, lane 2 corresponds to the flow through, lane 3-5 correspond to the 1st 
wash, 2nd wash, and 3rd wash respectively. Lanes 6-7 each corresponds to GST-RING_sl protein. Lane 8 
corresponds to the NaCl wash. Purified GST-RING_sl was cleaved (B) using 3C protease and GST was 
removed by the second round of glutathione agarose chromatography. Lane 1: uncleaved GST-RING_sl, 
lane 2: cleaved GST-RING_sl, lane 3 flow through containing RING_sl, lane 4: wash, lane 5 & 6 eluted 
GST. RING_sl has an apparent molecular weight of 14-20 kD when visualised on an SDS PAGE gel, 
suggesting that is partially dimeric. Lane M corresponds to the protein molecular weight marker. 
 
 
 
B 
A 
 
 
 
 
QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
 
 
QuickTime™ and a
TIFF (LZW) decompressor
are needed to see this picture.
 
 
Figure 3.8 Removal of residual GST from RING_sl by anion exchange chromatography. (A) Peak 1 
corresponds to the flow through, Peak 2 to RING_sl, and Peak 3 to GST. (B) SDS PAGE gel of fractions 
from the chromatogram. Lane 1 corresponds to RING_sl before anion exchange chromatography, lane 2 
corresponds to the fraction in Peak 2. Lane 5 corresponds to the fraction in Peak 3. Lane M is the protein 
molecular weight marker. 
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Figure 3.9 Removal of residual GST and small molecules from RING_sl by size exclusion 
chromatography. (A) Peak 1 corresponds to GST and peak 2 to RING_sl. A clear separation of GST and 
RING_sl was achieved. (B) SDS PAGE gel of fractions from the chromatography. Lane 1 corresponds to 
the void volume and lanes 2&3 correspond to peak 1 (GST). Lanes 4-8 correspond to peak 2 (RING_sl). 
Lane M corresponds to the protein molecular weight marker. Note that RING_sl consistently shows an 
apparent molecular weight consistent with it being a dimmer, despite the presence of 1 mM DTT. 
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Figure 3.10 Removal of residual GST and small molecules from purified RING_ss domain by size 
exclusion chromatography. (A) Peak 1 corresponds to proteins with high molecular weight, peak 2 to 
GST and peak 3 to RING_ss. A clear separation of GST and RING_sl was achieved. (B) SDS PAGE gel of 
fractions from the chromatography. Lane 1 corresponds to the void volume (peak 1), lane 2 corresponds to 
peak 2 (GST), Lanes 4-8 correspond to peak 3 (RING_ss). Lane 9 corresponds to RING_ss before putting it 
on the gel filtration column, and lane M corresponds to the protein molecular weight marker. The gel 
reveals that after gel filtration RING_ss still appears to be monomeric (~14.4 and 10.0 kD). 
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Figure 3.11 Coomasie Blue stained proteins analysed using 16 % SDS PAGE gel electrophoresis 
showing the final concentrated RING_sl in 5 mM DTT. Lane 1 corresponds to concentrated RING_sl, 
and lane M corresponds to the protein molecular weight marker. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.1 Absorbance of the Bradford reagent measured at 595 nm for the standard protein (BSA) and 
RING_sl. 
Concentration 
of standard 
protein (μg/ml) 
Absorbance of 
standard protein 
(595 nm) 
0 0 
10 0.172 
20 0.403 
30 0.544 
40 0.637 
50 0.776 
Dilutions for 
RING_sl 
Abs for RING_sl 
1:1000 0.4685 
1:2000 0.237 
 
y = 0.0164x
R2 = 0.975
0
0.1
0.2
0.3
0.4
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Figure 3.12 Bradford Assay standard curve for quantifying the concentration of RING_sl. A595 values 
of the standard protein (BSA) concentrations are plotted against different concentrations. The unknown 
concentration of RING_sl is determined using the measured absorbance values at two different dilutions. 
The dashed and continuous lines correspond to 1:1000 and 1:2000 dilutions respectively. The values 
corresponding to the concentration are calculated using the formula corresponding to the straight line fitted 
to the data. 
 
 
 
 
  
 
 
Figure 3.13 UV absorption spectrum of RING_sl protein determined using NanoDrop spectrometer. 
The large broad peak at 280 nm indicates the amount of protein available, and the absorbance value of 9.14, 
measured at an optical path length of 10 mm.  
 
 
 
 
 
 
 
 
 
 
 
  
Figure 4.1 1D spectra of shortened RING constructs, pH6.0, 25 oC, recorded at 600 MHz. A is the 
RING_sl and B is the RING_ss. In (A) the appearance of the resonances aromatic in the region (9-7.5 
ppm), α-protons in the region (7.5- 4.5 ppm), β-protons region (4.5-3.5 ppm), and methyl protons in the 
region (3.5-0 ppm) indicate that RING_sl is folded. In (B) the absence of the α-protons in the regions 7.5-
4.5 ppm, and the methyl protons in the region between 1-0 ppm indicate that RING_ss is unfolded. 
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Figure 4.2 15N-HSQC spectra of RING constructs, pH 6.0, 25 oC, recorded at 600 MHz. A is the 
RING_sl and B is the RING_ss. (A) 15N-HSQC spectrum for RING_sl, the resonances are sharp and well 
dispersed in both dimensions, which is characteristic of folded proteins. There are also more peaks. The NH2 
groups at the top right are also well dispersed. (B) 15N-HSQC spectrum for RING_ss, the resonances are 
broad and poorly dispersed in the HN dimension, which is characteristic of unfolded proteins. The NH2 groups 
at top right are also poorly dispersed.  
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Figure 4.3 Overlay 15N-HSQC spectra of RING_sl (black) domain and previous RING full (red) 
constructs, pH 6.0, 25 oC, recorded at 600 MHz. As shown RING_sl and the previous construct are well 
folded since the signals are well dispersed on both dimensions. The spectrum shows that RING_sl adopts 
the same structure as the previous RING construct.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4 Determination of molecular mass of RING_sl using mass spectrometer. The expected mass for 
RING_sl is 10229.6, for 15N-labelled RING_sl is 10351.6 Da, since 122 Da is added to every nitrogen, and for, 
Zn2+ bound 15N-labelled RING_sl  is 10417.009 Da if one Zn2+ is bound and 10482.418 Da if two Zn2+ are 
bound. The results show the mass of the protein without any Zn2+ bound, corresponding to 10349.00 Da. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5 1D spectra of RING_sl at different pH conditions. Unlabelled RING_sl sample was prepared in five 
different pH buffers (A) pH 6.0, (B) pH 5.8, (C) pH 5.6, and (D) pH 5.2 The protein start to unfold at pH 5.6 as 
shown by the disappearance of resonances between to the left of 9 ppm and at 0.1 ppm. By pH 5.2 RING_sl is almost 
completely unfolded. 
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Figure 4.6 Separation of the unfolded/aggregated protein from the folded protein and the removal of 
excess Cadmium/Zinc to determine the stability of Cadmium/Zinc in RING_sl using size exclusion 
chromatography. Peak 1 and peak 2 correspond to RING_sl. SDS PAGE gel analysis confirms that both peaks 
contain RING_sl protein. Lane 1,2,3, and 4 contain fractions that correspond to the broad peak, and lanes 5 to 8 
contain fractions that correspond to the narrow peak, lane 9 is the protein before gel filtration purification. M 
correspond to the protein molecular weight marker. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7 15N-HSQC spectra of RING_sl, pH 6.0, 25 oC, recorded at 600 MHz, showing the removal of 
excess cadmium/zinc, and aggregated protein using size exclusion chromatography. After purification the 
chromatogram contained the sharp peak corresponding to spectrum in (A & D), and the broad peak corresponding 
to (B & E). CdCl2 /ZnCl2 was added to the unfolded protein (broad peak) giving a spectrum in (C & F) in which 
the protein has refolded.  
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Figure 4.8 Superimposition of 15N-HSQC spectra of RING_sl, pH 6.0, 25 oC, recorded at 600 MHz, 
before (black) and 2 weeks after (red) the addition of 2 mM 113Cd-EDTA. Some resonances have shifted 
after the addition of  113Cd-EDTA, indicating that exchange has taken place.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9 Cadmium- zinc exchange experiments monitored by 1D directly detected and correlation 
experiments. (A) 1D directly detected 113Cd spectrum of RING_sl in the presence of 113Cd-EDTA. The 
resonance at 556.630 corresponds to 113Cd-EDTA and the two resonances at 82.448 and 63.950 to the two 
113Cd ions bound to the protein. (B) 113Cd-HSQC spectra of RING_sl in the presence of 113Cd-EDTA. The 
projection of the 113Cd-HSQC on the right hand side is the same as the 1D directly detected spectrum (A).  
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Figure 4.10 113Cd-HSQC spectrum of the cadmium-exchanged RING_sl. Expanded form of 4.9B 
(circled), showing two lines of peaks, each representing correlation transfer between one of the 113Cd2+ ions 
and the Hβ protons of the coordinating cysteines residues.  
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